↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

1,364 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 **comment**- imp inhalation solution identical to ventavis inhalation solution, but imp is in a different volume presentation. please see covering letter. - - - - 1件: 86 💬
2 0.9% normal saline (control) - - - - 1件: 299 💬
3 0.9% sodium chloride Chloride ion 1件: D02056 💬 - - 4件:  6 , 14, 51, 53 💬
4 0.9% sodium chloride (normal saline) Chloride ion 1件: D02056 💬 - - 1件:  6  💬
5 0.9% sodium chloride injection Chloride ion 1件: D02056 💬 - - 1件: 168 💬
6 0.9% w/v isotonic sodium chloride solution Chloride ion 1件: D02056 💬 - - 1件: 50 💬
7 0.9% w/v sodium chloride solution Chloride ion 1件: D02056 💬 - - 1件: 299 💬
8 100 mg elx/50 mg tez/75 mg iva fixed dose combination - - - - 1件: 299 💬
9 13 valent conjugated pneumococcal vaccine - - - - 1件: 265 💬
10 13-valent pneumococcal conjugate vaccine - - - - 2件: 46, 53 💬
11 13-valent pneumococcal conjugate vaccine (13-pcv) - - - - 1件: 13 💬
12 13-valent pneumococcal conjugated vaccine (pcv13) - - - - 1件: 96 💬
13 15 o water Water 1件: D00001 💬 - - 1件: 19 💬
14 15-o labeled water Water 1件: D00001 💬 - - 1件: 46 💬
15 150 mg double-blinded secukinumab Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
16 150 mg open-label secukinumab Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
17 20mg/0.5ml glatiramer acetate Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
18 3-hydroxy-2-methyl-4h-pyrane-4-one iron (iii) complex (3:1), ferric (3-hydroxy-2-methyl-4-pyrone), tris-maltol-iron (iii), tri=maltol-iron (iii) Tromethamine 1件: D00396 💬 - - 2件: 96, 97 💬
19 300 mg double-blinded secukinumab Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
20 40 mg glatiramer acetate Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 2件:  2 , 13 💬
21 40 mg glatiramer acetato Glatiramer 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
22 5 asa, enemas, suppositories, corticosteroids - - - - 1件: 97 💬
23 5% glucose water solution Dextrose, unspecified form 1件: D00001 💬 - - 1件:  2  💬
24 5% lidocaine/5 mg/ml 0.02% estradiol compound cream Estradiol 11件: D00105, D00358, D01413, D01617, D01953, D02086, D04061, D04063, D04064, D04065, D08127 💬 7件: ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 12件: Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway 1件: 226 💬
25 5-probe cocktail - - - - 1件: 254 💬
26 50 mg elx/25 mg tez/37.5 mg iva fixed dose combination - - - - 1件: 299 💬
27 5000 iu of cholecalciferol Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 299 💬
28 7-valent pneumococcal conjugate vaccine - - - - 1件: 46 💬
29 90 mg hydrocortisone acetate suppository with sephure suppository applicator Acetate 2件: D00088, D00165 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
30 A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine Clarithromycin 3件: D00276, D00278, D00424 💬 - - 1件: 96 💬
31 A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (cbus) - - - - 1件: 60 💬
32 A natural remedy for rheumatoid arthritis vs. common drugs - - - - 1件: 46 💬
33 A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (neogaa) Avalglucosidase alfa 1件: D11744 💬 1件: GAA 💬 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 1件: 256 💬
34 Aav9-cag-coh-sgsh - - - - 1件: 19 💬
35 Aavrh.10cuhcln2 vector 2.85x10^11 genome copies - - - - 1件: 19 💬
36 Aavrh.10cuhcln2 vector 9.0x10^11 genome copies - - - - 1件: 19 💬
37 Ace-031 (extension of cohort 1 from core study, a031-03) - - - - 1件: 113 💬
38 Ace-031 (extension of cohort 2 from core study, a031-03) - - - - 1件: 113 💬
39 Ace-031 (extension of cohort 3 from core study, a031-03) - - - - 1件: 113 💬
40 Acei/arb and corticosteroids - - - - 1件: 66 💬
41 Acomplia 20 mg film-coated tablets - - - - 1件: 193 💬
42 Active comparator - - - - 2件:  6 , 46 💬
43 Active comparator receiving extavia® - - - - 1件: 13 💬
44 Active control - - - - 1件: 13 💬
45 Actonel 5mg film coated tablets - - - - 1件: 274 💬
46 Actonel once a week 35 mg film-coated tablets - - - - 1件: 274 💬
47 Actonel once a week 5mg film coated tablets - - - - 1件: 113 💬
48 Actonel/optinate 5mg film-coated tablets - - - - 1件: 274 💬
49 Ada umbilical cord blood cells - - - - 1件: 65 💬
50 Adcirca 20 mg film-coated tablets - - - - 1件: 86 💬
51 Adempas - 0,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 1件: 86 💬
52 Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
53 Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
54 Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
55 Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
56 Adempas 0.5 mg film coated tablet - - - - 1件: 86 💬
57 Adempas 1 mg film coated tablet - - - - 1件: 86 💬
58 Adempas 1.5 mg film coated tablet - - - - 1件: 86 💬
59 Adempas 2 mg film coated tablet - - - - 1件: 86 💬
60 Adempas 2.5 mg film coated tablet - - - - 1件: 86 💬
61 Adempas® 0.5 mg film-coated tablets - - - - 1件: 86 💬
62 Adempas® 1.0 mg film-coated tablets - - - - 1件: 86 💬
63 Adempas® 1.5 mg film-coated tablets - - - - 1件: 86 💬
64 Adempas® 2.0 mg film-coated tablets - - - - 1件: 86 💬
65 Adempas® 2.5 mg film-coated tablets - - - - 1件: 86 💬
66 Adempas¿ 0.5 mg compressa rivestita con film - - - - 1件: 86 💬
67 Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene - - - - 1件: 113 💬
68 Adeno-associated viral vector serotype 9 containing the human n-acetyl-alpha-glucosaminidase gene - - - - 1件: 19 💬
69 Adipose-cord mesenchymal stromal cells (a-mscs) Human Umbilical Cord Mesenchymal Stem Cells - - - 1件: 97 💬
70 Adjuvant without active component - - - - 2件:  6 , 17 💬
71 Adrenal cortical hormone - - - - 1件: 224 💬
72 Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994 Alemtuzumab 1件: D02802 💬 - - 1件: 46 💬
73 Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994) Alemtuzumab 1件: D02802 💬 - - 1件: 46 💬
74 Alkalinized lidocaine-heparin Heparin 4件: D00358, D02086, D07510, D08127 💬 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 1件: 226 💬
75 Allogeneic human umbilical cord tissue-derived mesenchymal stem cells - - - - 1件: 13 💬
76 Allogeneic mesenchymal stromal cells derived from the umbilical cord Human Umbilical Cord Mesenchymal Stem Cells - - - 1件: 49 💬
77 Ambrisentan 5 mg film-coated tablets Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
78 Ambrisentan 5mg film-coated tablets [marketed product] Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
79 Amiodarone Amiodarone 2件: D00636, D02910 💬 16件: ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 31件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 2件: 28, 127 💬
80 Amitriptyline, fluoxetine and tramadol alone (control group) Amitriptyline 6件: D00326, D00809, D00823, D01355, D07448, D08623 💬 3件: OPRM1, SLC6A2, SLC6A4 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件: 78 💬
81 Ammonium chloride Ammonium chloride 1件: D01139 💬 - - 1件: 96 💬
82 Androgel 10 grams of gel containing 100 mg of testosterone Testosterone 6件: D00075, D00957, D00958, D00959, D06085, D06087 💬 1件: AR 💬 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer 1件: 13 💬
83 Angiotensin-converting enzyme (ace) inhibitor Angiotensin II 2件: D00150, D02014 💬 2件: AGTR1, AGTR2 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 224 💬
84 Angiotensin-converting enzyme inhibitor(acei) Angiotensin II 2件: D00150, D02014 💬 2件: AGTR1, AGTR2 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 224 💬
85 Anti human granulocyte-macrophage colo - - - - 1件: 46 💬
86 Anti human granulocyte-macrophage colony-stimulating factor (gm-csf) monoclonal - - - - 1件: 46 💬
87 Anti human granulocyte-macrophage colony-stimulating factor (gm-csf) monoclonal antibody - - - - 1件: 46 💬
88 Anti tnf humanized antibody fab fragment-peg conjugate - - - - 1件: 96 💬
89 Anti-tnf humanized antibody fab fragment - peg conjugate - - - - 1件: 46 💬
90 Anti-tnf humanized antibody fab' fragment - peg conjugate - - - - 1件: 46 💬
91 Anti-tnfa continued perioperatively - - - - 1件: 46 💬
92 Antibiotic cocktail - - - - 1件: 97 💬
93 Antimicrobial therapy: co-trimoxazole or doxycycline Doxycycline 5件: D00307, D02129, D03903, D03904, D07876 💬 - - 1件: 85 💬
94 Antioxidant cocktail - - - - 1件: 299 💬
95 Arcoxia 90 mg comprimidos recubiertos con película - - - - 1件: 271 💬
96 Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis) Atazanavir 3件: D00427, D01276, D07471 💬 - - 1件: 265 💬
97 Atg conditioning regimen - - - - 1件: 60 💬
98 Aubagio - 14 mg - compressa rivestita con film - uso orale - blister (alu/alu) - 28 compresse - - - - 1件: 13 💬
99 Autologous (self) mononuclear cells derived from umbilical cord blood - - - - 1件: 211 💬
100 Autologous cd34+ cells transduced with a lentiviral vector containing the human sgsh gene - - - - 1件: 19 💬
101 Autologous cd34+ cells transduced with the lentiviral vector containing the human wiskott aldrich sy - - - - 1件: 65 💬
102 Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with lentiviral vector that encodes for the human wiskott aldrich syndrome (was) cdna sequence - - - - 1件: 65 💬
103 Autologous human placental cord blood mononuclear cells - - - - 1件: 211 💬
104 Autologous umbilical cord blood - - - - 2件: 211, 294 💬
105 Avalox - 400 mg compresse rivestite con film 5 compresse in blister pp/al - - - - 1件:  6  💬
106 Avonex/betaseron/copaxone/rebif - - - - 1件: 13 💬
107 Azd4017 and prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 75 💬
108 Azilect 1 mg comprimidos - - - - 2件:  6 , 17 💬
109 Azithromycin + n-acetylcystein + inhaled corticosteroid Azithromycin 3件: D02134, D06390, D07486 💬 - - 1件: 228 💬
110 Azithromycin 500 mg film-coated tablet Azithromycin 3件: D02134, D06390, D07486 💬 - - 1件: 299 💬
111 B-peptide-crm197 conjugate - - - - 1件: 11 💬
112 Balsalazide Balsalazide 2件: D02715, D07488 💬 - - 1件: 97 💬
113 Balsalazide disodium Balsalazide 2件: D02715, D07488 💬 - - 1件: 97 💬
114 Bay 63-2521 coated tablets 0.5 mg - - - - 2件: 86, 88 💬
115 Bay 63-2521 coated tablets 1 mg - - - - 2件: 86, 88 💬
116 Bay 63-2521 coated tablets 1.5 mg - - - - 2件: 86, 88 💬
117 Bay 63-2521 coated tablets 2 mg - - - - 2件: 86, 88 💬
118 Bay 63-2521 coated tablets 2.5 mg - - - - 2件: 86, 88 💬
119 Bay 63-2521 ir coated tablet 1.0 mg - - - - 1件: 88 💬
120 Bay 63-2521 ir coated tablet 1.5 mg - - - - 1件: 88 💬
121 Bay 63-2521 ir coated tablet 2.0 mg - - - - 1件: 88 💬
122 Bay 63-2521 ir coated tablet 2.5 mg - - - - 1件: 88 💬
123 Befizal l.p. 400 mg, comprimé enrobé à libération prolongée - - - - 1件: 94 💬
124 Behavioral: adherence counseling - - - - 1件: 13 💬
125 Behavioral: assessment of cognition - - - - 1件:  6  💬
126 Behavioral: assessment of impact of ms on cognition - - - - 1件: 13 💬
127 Behavioral: assessment of severity of icd (impulse control disorders) - - - - 1件:  6  💬
128 Behavioral: attention control - - - - 1件:  6  💬
129 Behavioral: co-op treatment protocol - - - - 1件:  6  💬
130 Behavioral: cognitive and behavioral experimental tasks - - - - 2件:  6 , 127 💬
131 Behavioral: collaborative care (cc) - - - - 1件: 13 💬
132 Behavioral: colonic lavage - - - - 1件: 291 💬
133 Behavioral: combined balance and brisk walking training Isoxaflutole - - - 1件:  6  💬
134 Behavioral: conservative measures for orthostatic hypotension - - - - 2件:  6 , 17 💬
135 Behavioral: conservative treatment - - - - 1件: 291 💬
136 Behavioral: diet and water adjustment Water 1件: D00001 💬 - - 1件: 67 💬
137 Behavioral: diet counseling - - - - 1件: 96 💬
138 Behavioral: dietary counseling - - - - 1件: 46 💬
139 Behavioral: healthy age-matched controls - - - - 1件:  6  💬
140 Behavioral: increased dietary intake of salmon or cod Salmon, unspecified - - - 1件: 97 💬
141 Behavioral: low-impact exercise control - - - - 1件:  6  💬
142 Behavioral: montreal cognitive assessment (moca) - - - - 1件: 17 💬
143 Behavioral: protein and calorie controlled diet - - - - 1件: 251 💬
144 Behavioral: respiratory and exercise therapy with supplemental oxygen Oxygen 1件: D00003 💬 - - 1件: 88 💬
145 Behavioral: telephone-based cognitive behavioral therapy - - - - 1件: 13 💬
146 Behavioral: tip / impact plus care coordination - - - - 3件: 46, 96, 97 💬
147 Behavioral: water tracking Water 1件: D00001 💬 - - 1件: 13 💬
148 Benlysta - 120 mg - polvere per concentrato per soluzione per infusione - uso endovenoso - flaconcino (vetro) 120 mg 1 flaconcino - - - - 1件: 53 💬
149 Benlysta 400 mg powder for concentrate for solution for infusion - - - - 2件: 43, 49 💬
150 Benlysta 400 mg powder for concentrate for solution for infusions - - - - 1件: 49 💬
151 Benlysta 400mg polvere per concentrato per soluzione per infusione - - - - 1件: 43 💬
152 Berberine Berberine 1件: D00092 💬 - - 1件: 97 💬
153 Berberine chloride Berberine 1件: D00092 💬 - - 1件: 97 💬
154 Beta-adrenergic cocktail - - - - 1件: 299 💬
155 Biib033 (anti-lingo) - ev substance code sub118957 - - - - 1件: 13 💬
156 Bio-enhanced curcumin soft gelatin capsule Curcumin 2件: D00115, D06892 💬 - - 1件: 97 💬
157 Biological: umbilical cord based allogenic mesenchymal stem cell - - - - 1件: 113 💬
158 Bladder instillation with heparin/ lidocaine Heparin 4件: D00358, D02086, D07510, D08127 💬 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 1件: 226 💬
159 Blokium 50 mg comprimidos - - - - 1件: 167 💬
160 Blood coagulation factor viii and vwf, human Beroctocog alfa - - - 1件: 288 💬
161 Blood coagulation factor xiii Factor XIII (human) - - - 1件: 51 💬
162 Blood collection - - - - 1件: 271 💬
163 Blood sample collection - - - - 1件: 85 💬
164 Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) Digoxin 13件: D00298, D00330, D00455, D00529, D00550, D00696, D01207, D01475, D02290, D05028, D05259, D05261, D08229 💬 25件: ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 49件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
165 Bone marrow concentrate - - - - 1件: 70 💬
166 Boots high strength garlic odour controlled Garlic - - - 1件: 299 💬
167 Botulinum toxin a - haemagglutinin complex Botulinum toxin type A 1件: D00783 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 1件: 13 💬
168 Bovine type i collagen Bovine type I collagen - - - 1件: 51 💬
169 Bpr277 ointment (controlled application) - - - - 1件: 160 💬
170 Bupivacaine/epinephrine/dexamethasone Bupivacaine 14件: D00095, D00292, D00975, D00996, D01450, D01510, D01615, D01632, D01948, D02149, D02174, D02591, D02592, D07552 💬 15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 96 💬
171 Busilvex - 6 mg/ml - concentrato per soluzione per infusione - uso endovenoso - flaconcino - 10 ml 8 flaconcini - - - - 2件: 19, 65 💬
172 Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen) Antithymocyte immunoglobulin (rabbit) 5件: D00248, D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 326 💬
173 C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker Polyethylene glycol 1件: D03370 💬 - - 1件: 276 💬
174 C1 inhibitor concentrate Human C1-esterase inhibitor - - - 1件: 65 💬
175 Cabozantinib Cabozantinib 1件: D10062 💬 3件: AXL, KDR, MET 💬 24件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 1件: 34 💬
176 Calcium and cholecalciferol Calcium 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 46 💬
177 Calcium and vitamin d combination Calcium - - - 1件: 13 💬
178 Canakinumab (company code: acz885d) Canakinumab 1件: D09315 💬 1件: IL1B 💬 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 1件: 106 💬
179 Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
180 Carbidopa, levodopa, entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
181 Carbidopa/l-dopa/entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
182 Carbidopa/levodopa/entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
183 Carvedilol Carvedilol 2件: D00255, D03415 💬 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 5件:  6 , 57, 86, 113, 210 💬
184 Cbdv compound Cannabidivarin - - - 1件: 193 💬
185 Cellcept 500 mg comprimidos recubiertos - - - - 1件: 35 💬
186 Cellcept 500 mg film-coated tablets - - - - 1件: 11 💬
187 Cellcept®500 mg comprimidos - - - - 1件: 35 💬
188 Cellule cd34+ autologhe trasdotte con idua lv codificante per il cdna dell'alfa-l-iduronidasi - - - - 1件: 19 💬
189 Cfz533 active - cohort 1 - - - - 1件: 53 💬
190 Cfz533 active - cohort 2 - - - - 1件: 53 💬
191 Cfz533 active - cohort 3 - - - - 1件: 53 💬
192 Cfz533 active -cohort 3 - - - - 1件: 53 💬
193 Chemical conjugate of recombinant human growth hormone (rhgh) and human immunoglobulin g4 fragment (hmc001) Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 78 💬
194 Chicken type ii collagen Chicken - - - 1件: 46 💬
195 Chinese herbal concoction twice a day for 6 months - - - - 1件: 60 💬
196 Chlorpromazine Chlorpromazine 4件: D00270, D00789, D03274, D04034 💬 13件: ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C 💬 22件: Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 254 💬
197 Chlorpromazine hydrochloride Chlorpromazine 4件: D00270, D00789, D03274, D04034 💬 13件: ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C 💬 22件: Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 254 💬
198 Cholecalciferol Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
199 Cholecalciferol (vitamin d3) Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 2件: 13, 299 💬
200 Cholecalciferol (vitamind3) Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 299 💬
201 Cholecalciferol 10,000 iu Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 96 💬
202 Cholecalciferol 400 iu Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 96 💬
203 Cholecalciferol and c. xanthorrhiza Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 49 💬
204 Cholecalciferol concentrate Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 96 💬
205 Cholecalciferol concentrate (water-dispersible form) Cholecalciferol 2件: D00001, D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 96 💬
206 Cholecalciferol, vitamin d3 Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 13 💬
207 Chronic corticosteroid therapy - - - - 1件: 113 💬
208 Cialis - 20 mg 2 compresse rivestite con film in blister uso orale - - - - 1件: 75 💬
209 Cialis 10 mg film-coated tablets - - - - 2件: 86, 113 💬
210 Cialis 2.5 mg film-coated tablets - - - - 2件: 86, 113 💬
211 Cialis 20 mg comprimidos recubiertos con película - - - - 1件: 86 💬
212 Cialis 20 mg film-coated tablets - - - - 2件: 86, 113 💬
213 Cialis 5 mg film-coated tablets - - - - 2件: 86, 113 💬
214 Circadin 2 mg comprimidos de liberación prolongada - - - - 1件: 90 💬
215 Claritromycin 500mg film coated tablets - - - - 1件: 299 💬
216 Clenbuterol Clenbuterol 1件: D07713 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 4件:  1 ,  2 ,  6 , 256 💬
217 Clenbuterol hcl Clenbuterol 1件: D07713 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
218 Clenbuterol hydrochloride Clenbuterol 1件: D07713 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
219 Clobetasol propionate Clobetasol 2件: D01272, D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 46, 162 💬
220 Clobetasol propionate + methotrexate Clobetasol 4件: D00142, D01272, D02115, D07715 💬 3件: DHFR, DHFR2, NR3C1 💬 6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 1件: 162 💬
221 Clobetasol propionate alone Clobetasol 2件: D01272, D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
222 Clobetasol propionate cream treatment Clobetasol 2件: D01272, D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
223 Co - - - - 5件:  6 , 13, 53, 70, 85 💬
224 Co-14 - - - - 1件: 13 💬
225 Co-medication: synthetic dmards - - - - 1件: 46 💬
226 Co-trimoxazole - - - - 1件: 85 💬
227 Coa - - - - 1件: 120 💬
228 Coagulación factor viii Beroctocog alfa - - - 1件: 288 💬
229 Coagulation factor viii Beroctocog alfa - - - 1件: 288 💬
230 Coagulation factor xiii Factor XIII (human) - - - 1件: 288 💬
231 Coamoxiclav - - - - 1件: 97 💬
232 Cobalt Cobalt - - - 1件: 46 💬
233 Cobamamide Cobamamide 1件: D00042 💬 - - 1件: 299 💬
234 Cobiprostone Cobiprostone 1件: D08893 💬 - - 1件: 46 💬
235 Cobitolimod Cobitolimod - - - 1件: 97 💬
236 Cocoa Cocoa - - - 1件:  6  💬
237 Coconut Coconut - - - 2件: 13, 53 💬
238 Coconut oil Coconut 1件: D05326 💬 - - 1件: 13 💬
239 Coconut oil and epigallocatechin gallate Coconut 1件: D05326 💬 - - 1件: 13 💬
240 Cod - - - - 1件: 46 💬
241 Cod liver oil Cod liver oil 1件: D03578 💬 - - 1件: 46 💬
242 Coenzym q10 nanodispersion - - - - 1件:  5  💬
243 Coenzym q10, ubiquinon, ubichinon - - - - 1件:  5  💬
244 Coenzyme q - - - - 1件: 13 💬
245 Coenzyme q-10 Ubidecarenone 1件: D01065 💬 - - 1件: 86 💬
246 Coenzyme q-10 in normal control subjects Ubidecarenone 1件: D01065 💬 - - 1件: 86 💬
247 Coenzyme q-10 in pulmonary hypertension subjects Ubidecarenone 1件: D01065 💬 - - 1件: 86 💬
248 Coenzyme q10 Ubidecarenone 1件: D01065 💬 - - 12件:  2 ,  5 ,  6 ,  8 , 10, 18, 46, 57, 113, 193, 214, 215 💬
249 Coenzyme q10 and lisinopril Lisinopril 3件: D00362, D01065, D08131 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 1件: 113 💬
250 Coenzyme q10 nanodispersion (nanoquinone) Ubidecarenone 1件: D01065 💬 - - 1件:  6  💬
251 Coenzyme q10 with vitamin e Ubidecarenone 2件: D01065, D02331 💬 - - 1件:  6  💬
252 Coenzymeq10 - - - - 1件: 21 💬
253 Cofactor - - - - 3件:  6 , 265, 288 💬
254 Cofactor supplementation (thiamine, riboflavin, l-carnitine) Levocarnitine 7件: D00050, D01622, D01913, D02030, D02176, D04713, D08580 💬 - - 1件: 265 💬
255 Coffee - - - - 2件: 96, 97 💬
256 Coffee coal - - - - 1件: 97 💬
257 Cogane - - - - 1件:  6  💬
258 Cogane™ (pym50028) - - - - 1件:  6  💬
259 Cohort 1 0.225g - - - - 1件: 240 💬
260 Cohort 1: 1.0 x 10^8 polytregs - - - - 1件: 35 💬
261 Cohort 1: hatg, csa, epag day 14 to month 6 Antilymphocyte immunoglobulin (horse) 1件: D08808 💬 - - 1件: 60 💬
262 Cohort 1:nilotinib oral capsules (150mg or 300mg) Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
263 Cohort 2 0.75g - - - - 1件: 240 💬
264 Cohort 2: 2.5x10^8 polytregs - - - - 1件: 35 💬
265 Cohort 2: hatg, csa, epag day 14 to month 3 Antilymphocyte immunoglobulin (horse) 1件: D08808 💬 - - 1件: 60 💬
266 Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1) Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
267 Cohort 3 2.25 g - - - - 1件: 240 💬
268 Cohort 3: hatg, csa (dose reduced), epag day 1 to month 6 Antilymphocyte immunoglobulin (horse) 1件: D08808 💬 - - 1件: 60 💬
269 Col7a1-sin retroviral vector engineered autologous tissue-engineered skin - - - - 1件: 36 💬
270 Colal pred - - - - 1件: 97 💬
271 Colal-pred - - - - 1件: 97 💬
272 Colal-pred® - - - - 1件: 97 💬
273 Colazide - - - - 1件: 97 💬
274 Colchicina Colchicine 1件: D00570 💬 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 1件:  2  💬
275 Colchicina lirca - 1 mg compresse 60 compresse Colchicine 1件: D00570 💬 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 1件:  2  💬
276 Colchicine Colchicine 1件: D00570 💬 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 7件:  2 , 42, 46, 56, 93, 210, 266 💬
277 Colchicine 1 mg oral tablet Colchicine 1件: D00570 💬 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 1件:  2  💬
278 Colchicine sprinkle capsules Colchicine 1件: D00570 💬 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 1件: 266 💬
279 Colecalciferol Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 4件: 13, 46, 96, 228 💬
280 Colecalciferol concentrate (oily form) Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 13 💬
281 Colecalciferol d3 (vigantol oil) Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 96 💬
282 Colesevelam Colesevelam 2件: D03582, D07743 💬 - - 2件: 96, 260 💬
283 Colestipol Colestipol 2件: D02113, D07771 💬 - - 1件: 254 💬
284 Colestyramine Cholestyramine - - - 1件: 254 💬
285 Colimicina - - - - 1件: 299 💬
286 Colimicina - 1000000 u/4 ml polvere e solvente per soluzione iniettabile per uso intramuscolare1 flaconcino polvere + 1 fiala solvente 4 ml - - - - 1件: 299 💬
287 Colimycine - - - - 1件: 299 💬
288 Colimycine inhalation - - - - 1件: 299 💬
289 Colimycine injectable - - - - 1件: 299 💬
290 Colistimetato sodico - - - - 1件: 299 💬
291 Colistimethat-natrium - - - - 1件: 299 💬
292 Colistimethate Colistimethate 1件: D02049 💬 - - 1件: 299 💬
293 Colistimethate 75 mg inhaled two times daily Colistimethate 1件: D02049 💬 - - 1件: 299 💬
294 Colistimethate sodium Colistimethate 1件: D02049 💬 - - 1件: 299 💬
295 Colistimethate sodium (a component) Colistimethate 1件: D02049 💬 - - 1件: 299 💬
296 Colistimethate sodium (ban, usan), colistimethatum natricum, colistin sodium methanesulfonate Colistimethate 3件: D02049, D02138, D07746 💬 - - 1件: 299 💬
297 Colistimethate sodium (promixin) Colistimethate 1件: D02049 💬 - - 1件: 299 💬
298 Colistin Colistin 2件: D02138, D07746 💬 - - 1件: 299 💬
299 Colistin cf Colistin 2件: D02138, D07746 💬 - - 1件: 299 💬
300 Colistin forest - trockenstechampullen mit lösungsmittel Colistin 2件: D02138, D07746 💬 - - 1件: 299 💬
301 Colistin mesilate sodium Colistin 2件: D02138, D07746 💬 - - 1件: 299 💬
302 Colistineb - - - - 1件: 299 💬
303 Colistineb 2mui - - - - 1件: 299 💬
304 Collagenase Collagenase clostridium histolyticum 1件: D09596 💬 - - 1件: 162 💬
305 Collect of 10 ml of peripheric blood for dna extraction - - - - 1件: 46 💬
306 Collection of blood and urine - - - - 1件: 25 💬
307 Colobreathe - - - - 1件: 299 💬
308 Colomycin - - - - 1件: 299 💬
309 Colony-purified bacteroides thetaiotaomicron (b.theta) - - - - 1件: 96 💬
310 Coltect - - - - 1件: 97 💬
311 Combination - - - - 1件: 46 💬
312 Combination antiviral therapy - - - - 1件: 93 💬
313 Combination fish oil and borage seed oil Fish oil - - - 1件: 46 💬
314 Combination injection of epo and g-csf Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件:  6  💬
315 Combination of a single dose anti-cd20 antibody and bortezomib Bortezomib 1件: D03150 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 61 💬
316 Combination of fish oil and colesevelam Colesevelam 2件: D03582, D07743 💬 - - 1件: 260 💬
317 Combination of minocycline and mtx or mtx alone Minocycline 2件: D00850, D05045 💬 - - 1件: 46 💬
318 Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine Azathioprine 12件: D00238, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994, D03033 💬 2件: MS4A1, NR3C1 💬 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 1件: 35 💬
319 Combination of thrombopoietin mimetic and cyclosporin a Cyclosporine 1件: D00184 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 60 💬
320 Combination oral budesonide and rectal hydrocortisone Budesonide 2件: D00088, D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
321 Combination product (natpara) and drug or supplements [disease and drug registry] - - - - 1件: 235 💬
322 Combination product: device: axially oscillating sphere dry powder inhaler (aos dpi) - - - - 1件: 86 💬
323 Combination product: active treatment with dual therapy - - - - 1件:  2  💬
324 Combination product: beclomethasone dipropionate in addition to mc-evoo Beclomethasone dipropionate 2件: D00689, D07495 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
325 Combination product: beclomethasone dipropionate in addition to refined oil Beclomethasone dipropionate 2件: D00689, D07495 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
326 Combination product: belimumab Belimumab 1件: D03068 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 1件: 49 💬
327 Combination product: goldic serum - - - - 1件: 70 💬
328 Combination product: hyperbaric oxygen therapy- Oxygen 1件: D00003 💬 - - 1件: 226 💬
329 Combination product: implantable system for remodulin (treprostinil) Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
330 Combination product: l-dopa 140 mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
331 Combination product: l-dopa 35 mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
332 Combination product: l-dopa 70mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
333 Combination product: l-dopa 70mg/carbidopa 7mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
334 Combination product: mavrilimumab Mavrilimumab 1件: D09930 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 1件: 41 💬
335 Combination product: methotrexate Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 46 💬
336 Combination product: nd0612 solution for sc infusion - - - - 1件:  6  💬
337 Combination product: ofatumumab with ai Ofatumumab 1件: D09314 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 13 💬
338 Combination product: ofatumumab with prf Ofatumumab 1件: D09314 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 13 💬
339 Combination product: prp combined magnovision - - - - 1件: 90 💬
340 Combination product: transcon pth - - - - 1件: 235 💬
341 Combination product: treprostinil via implanted pump Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
342 Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator Acetate 2件: D00088, D00165 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
343 Combination steroid - - - - 1件: 46 💬
344 Combination therapy with vigabatrin and prednisolone Prednisolone 9件: D00472, D00535, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 2件: ABAT, NR3C1 💬 8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件: 145 💬
345 Combined plasma exchange (pex), rituximab, and corticosteroids Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 85 💬
346 Combivir - - - - 1件: 265 💬
347 Combivir (zidovudine [azt] / lamivudine [3tc]) Lamivudine 2件: D00353, D00413 💬 - - 1件: 265 💬
348 Commercial formulation etanercept Etanercept 1件: D00742 💬 2件: LTA, TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
349 Commercial ventavis® (iloprost) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
350 Common name: sialic acid - - - - 1件: 30 💬
351 Comparator: carbidopa Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
352 Comparator: diclofenac Diclofenac 3件: D00903, D00904, D07816 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 46 💬
353 Comparator: diclofenac sodium Diclofenac 3件: D00903, D00904, D07816 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 46 💬
354 Comparator: ezetimibe Ezetimibe 1件: D01966 💬 1件: NPC1L1 💬 1件: Fat digestion and absorption 2件: 79, 260 💬
355 Comparator: levodopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
356 Comparator: naproxen tablet 500 mg Naproxen 1件: D00118 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 46 💬
357 Complement c1 esterase inhibitor Conestat alfa 1件: D10845 💬 3件: C1R, C1S, KLKB1 💬 6件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 1件: 61 💬
358 Compound 1a - - - - 2件: 246, 299 💬
359 Compound 21 - - - - 1件: 85 💬
360 Compound thrombosis capsule sig: 1.5g/tid - - - - 1件: 90 💬
361 Comtan - - - - 1件:  6  💬
362 Comtan 200* 60 cpr 200 mg - - - - 1件:  6  💬
363 Comtan® - - - - 1件:  6  💬
364 Comtanâ® - - - - 1件:  6  💬
365 Comtess - - - - 1件:  6  💬
366 Comtess® - - - - 1件:  6  💬
367 Concentration unit: mg milligram(s) - - - - 1件: 254 💬
368 Concerta - - - - 1件: 203 💬
369 Conditioned medium (cm) - - - - 1件: 90 💬
370 Confortid - - - - 1件: 225 💬
371 Conivaptan Conivaptan 2件: D01236, D07748 💬 2件: AVPR1A, AVPR2 💬 5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 1件: 86 💬
372 Conjugated equine estrogens Conjugated estrogens 2件: D04070, D05987 💬 - - 1件: 49 💬
373 Conjugated equine estrogens 0.625 mg/d + mpa 5 mg/d/10d Conjugated estrogens 2件: D04070, D05987 💬 - - 1件: 49 💬
374 Continuation of azathioprine Azathioprine 2件: D00238, D03033 💬 - - 1件: 49 💬
375 Continuation of current haart (boosted protease inhibitor [pi] combination + 2 nrtis) - - - - 1件: 265 💬
376 Continuous apomorphine infusion Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
377 Continuous infusion cefepime Cefepime 1件: D02376 💬 - - 1件: 299 💬
378 Continuous infusion ceftazidime Ceftazidime 2件: D00921, D07654 💬 - - 1件: 299 💬
379 Continuous infusion meropenem Meropenem 2件: D02222, D08185 💬 - - 1件: 299 💬
380 Continuous infusion piperacillin tazobactam Piperacillin 4件: D00466, D00660, D02251, D08380 💬 - - 1件: 299 💬
381 Continuous infusion ticarcillin-clavulanate Clavulanic acid 2件: D07711, D08593 💬 - - 1件: 299 💬
382 Continuous intrajejunal infusion of levodopa-carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
383 Continuous oxygen Oxygen 1件: D00003 💬 - - 1件: 90 💬
384 Continuous release dopamine agonists Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
385 Continuous subcutaneous lisuride infusion Lisuride 2件: D01462, D08132 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
386 Contrast enhanced ultrasound - - - - 1件: 96 💬
387 Control - - - - 4件:  6 , 46, 168, 299 💬
388 Control group - - - - 3件:  2 , 46, 70 💬
389 Control group 0.9% isotonic saline - - - - 1件: 299 💬
390 Control intervention (no dexamethasone) Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
391 Control multivitamin - - - - 1件: 299 💬
392 Controlled-release levodopa / carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
393 Conventional - - - - 1件: 63 💬
394 Conventional dmard combination - - - - 1件: 46 💬
395 Conventional dmards - - - - 1件: 46 💬
396 Conventional drug therapy(expectorant,bronchodilator) - - - - 1件: 86 💬
397 Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) Acetate 21件: D00088, D00292, D00472, D00473, D00973, D00975, D00980, D00981, D00982, D01239, D01510, D01615, D01632, D01948, D01998, D02156, D02174, D02591, D02592, D03301, D07749 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
398 Conventional synthetic dmard - - - - 1件: 46 💬
399 Conventional therapy - - - - 2件: 67, 222 💬
400 Coozar - - - - 1件: 167 💬
401 Cop - - - - 1件: 13 💬
402 Cop-1 Glatiramer 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
403 Cop-1/copolymer-1 Glatiramer 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
404 Copaxone - - - - 1件: 13 💬
405 Copaxone - 20 mg/ml soluzione iniettabile in siringhe preriempite 30 siringhe - - - - 1件: 13 💬
406 Copaxone - 40 mg/ml soluzione iniettabile in siringa preriempita 12 siringhe preriempite da 1 ml con ago - - - - 1件: 13 💬
407 Copaxone 20 mg - - - - 1件: 13 💬
408 Copaxone 20 mg/ml - - - - 1件: 13 💬
409 Copaxone 20 mg/ml solución inyectable en jeringa precargada - - - - 1件: 13 💬
410 Copaxone 20 mg/ml solución para inyección en jeringa precargada - - - - 1件: 13 💬
411 Copaxone 20 mg/ml solution for injection, pre-filled syringe - - - - 1件: 13 💬
412 Copaxone 20 mg/ml, solution for injection, pre-filled syringes - - - - 1件: 13 💬
413 Copaxone 20mg/ml solution for injection, pre-filled syringe - - - - 1件: 13 💬
414 Copaxone 40 mg/ml - - - - 1件: 13 💬
415 Copaxone 40 mg/ml solution for injection, pre-filled syringe - - - - 1件: 13 💬
416 Copaxone subcutaneous injection syringe - - - - 1件: 13 💬
417 Copaxone*sc 28sir 20mg/ml - - - - 1件: 13 💬
418 Copaxone-teva - - - - 1件: 13 💬
419 Copaxone® - - - - 1件: 13 💬
420 Copegus - - - - 1件:  2  💬
421 Copolymer 1 - - - - 1件: 13 💬
422 Copolymer-1 Glatiramer 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
423 Copper Copper - - - 4件:  2 , 169, 170, 171 💬
424 Copper (64cu) chloride Chloride ion - - - 1件: 171 💬
425 Copper histidinate Copper - - - 1件: 169 💬
426 Copper histidine Copper 1件: D00032 💬 - - 2件: 169, 170 💬
427 Coq10 - - - - 3件:  5 ,  6 ,  8  💬
428 Coqun - - - - 1件: 90 💬
429 Cor-003 - - - - 1件: 75 💬
430 Cord blood - - - - 1件: 60 💬
431 Cord blood therapy Umbilical Cord Blood Hematopoietic Stem Cells - - - 2件:  2 ,  6  💬
432 Cord blood transplant - - - - 1件: 60 💬
433 Cord blood units - - - - 1件: 60 💬
434 Cordin - - - - 1件: 60 💬
435 Corn Corn - - - 2件: 46, 240 💬
436 Corn oil capsules Corn - - - 1件: 46 💬
437 Corn starch Starch, corn 1件: D05297 💬 - - 1件: 49 💬
438 Corn/soy oil Corn - - - 1件: 240 💬
439 Cornstarch Starch, corn 1件: D05297 💬 - - 2件: 90, 257 💬
440 Cornstarch control Starch, corn 1件: D05297 💬 - - 1件: 90 💬
441 Cort125134 Relacorilant 1件: D11336 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 75 💬
442 Cortancyl Prednisone acetate 1件: D08416 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 35, 41, 162 💬
443 Cortancyl 20 mg Prednisone acetate 1件: D08416 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 35, 162 💬
444 Cortancyl ® 1 mg Prednisone acetate 1件: D08416 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 41 💬
445 Cortancyl ® 20 mg Prednisone acetate 1件: D08416 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 41 💬
446 Cortancyl ® 5 mg Prednisone acetate 1件: D08416 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 41 💬
447 Cortecosteroid - - - - 1件: 96 💬
448 Cortef - - - - 3件:  6 , 81, 83 💬
449 Cortef (hydrocortisone) Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 83 💬
450 Cortef 5 mg - - - - 1件: 83 💬
451 Corticoids+ tocilizumab 8mg/kg/4 weeks Tocilizumab 1件: D02596 💬 1件: IL6R 💬 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 1件: 41 💬
452 Corticosteroid - - - - 10件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬
453 Corticosteroid (cs) - - - - 1件: 41 💬
454 Corticosteroid (prednisolone) Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 85 💬
455 Corticosteroid and azathioprine Azathioprine 2件: D00238, D03033 💬 - - 4件: 42, 43, 44, 45 💬
456 Corticosteroid and non-biological agents. - - - - 1件: 46 💬
457 Corticosteroid or nsaid - - - - 1件: 46 💬
458 Corticosteroid treatment (methylprednisolone or prednisolone) Methylprednisolone 14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 64 💬
459 Corticosteroids - - - - 10件: 41, 46, 49, 64, 97, 107, 164, 220, 296, 300 💬
460 Corticosteroids & tancart19/20 - - - - 1件: 13 💬
461 Corticosteroids (aprednislon) - - - - 1件: 63 💬
462 Corticosteroids (prednisone or prednisolone) Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 49 💬
463 Corticosteroids for systemic use - - - - 1件: 41 💬
464 Corticosteroids only - - - - 1件: 97 💬
465 Corticosteroids'therapy - - - - 1件: 35 💬
466 Corticotherapy - - - - 1件: 66 💬
467 Corticotrophin Corticotropin 1件: D00146 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 46 💬
468 Corticotrophin 80 units Corticotropin 1件: D00146 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 46 💬
469 Corticotropin Corticotropin 1件: D00146 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 7件:  2 , 13, 46, 75, 78, 84, 222 💬
470 Corticotropin-releasing hormone Corticorelin 2件: D00146, D03905 💬 3件: CRHR1, CRHR2, MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 75 💬
471 Cortimentmmx 9 mg - - - - 1件: 97 💬
472 Cortisol Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
473 Cortison - - - - 1件: 81 💬
474 Cortisone Cortisone 1件: D07749 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
475 Cortisone acetate Acetate 2件: D00973, D07749 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
476 Cosentyx - - - - 3件: 41, 269, 271 💬
477 Cosentyx® - - - - 1件: 269 💬
478 Cosmofer - - - - 3件: 86, 96, 97 💬
479 Cosmofer 50mg/ml solution for infusion or injection - - - - 2件: 96, 97 💬
480 Costicosteroids - - - - 1件: 26 💬
481 Cosyntropin Tetracosactide 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 3件: 83, 113, 145 💬
482 Cosyntropin acetate Acetate 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 113 💬
483 Cosyntropin injectable suspension 1 mg/ml + vigabatrin Tetracosactide 2件: D00284, D00535 💬 2件: ABAT, MC2R 💬 12件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 1件: 145 💬
484 Cosyntropin injectable suspension, 1 mg/ml Tetracosactide 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 145 💬
485 Cotrimoxazole - - - - 2件: 85, 97 💬
486 Cotton Cotton - - - 2件: 35, 162 💬
487 Coversin Nomacopan 1件: D11473 💬 1件: C5 💬 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 2件: 62, 109 💬
488 Coversyl - - - - 2件: 19, 167 💬
489 Coversyl (perindopril) Perindopril 2件: D00624, D03753 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 1件: 167 💬
490 Coversyl plus - - - - 1件: 19 💬
491 Cozaar - - - - 1件: 167 💬
492 Cozaar 50 - - - - 1件: 167 💬
493 Cozaar 50 mg comprimidos recubierto con pelicula - - - - 1件: 179 💬
494 Cozaar inicio 12,5 mg comprimidos recubiertos con pelicula - - - - 1件: 167 💬
495 Crestor film-coated tablet - - - - 1件: 79 💬
496 Crestor tablets (calcium rosuvastatin) film-coated tablets Calcium 2件: D01915, D08492 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 79 💬
497 Cryopreserved autologous cd34+ cells transduced with a lentiviral vector containing human sgsh gene - - - - 1件: 19 💬
498 Cs (corticosteroids) only - - - - 1件: 97 💬
499 Csm allogéniques issues de cordons ombilicaux ( mti-pp) - - - - 1件: 49 💬
500 Cumulative corticosteroid exposure - - - - 1件: 49 💬
501 Cuprior 150 mg film-coated tablets - - - - 1件: 171 💬
502 Cuprior 150mg film-coated tablets - - - - 1件: 171 💬
503 Currently available therapy in the community - - - - 1件: 51 💬
504 Cushing's syndrome confirmation - - - - 1件: 75 💬
505 Cyclophosphamide/glatiramer acetate Acetate 3件: D00287, D04318, D07760 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
506 Cyclosporine combine with mycophenolate mofetil Cyclosporine 5件: D00184, D00752, D05094, D05095, D05096 💬 7件: IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 35件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 283 💬
507 Cytotoxic combination - - - - 1件: 56 💬
508 D-methylphenidate Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 84 💬
509 D-sorbitol Sorbitol 1件: D00096 💬 - - 1件: 10 💬
510 D.3.2 product code where applicable13: - - - - 1件: 193 💬
511 Daratumumab co-formulated with recombinant human hyaluronidase (rhuph20) Daratumumab 4件: D04455, D04456, D06604, D10777 💬 1件: CD38 💬 7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 1件: 28 💬
512 Dark chocolate (85% cocoa) Cocoa - - - 1件:  6  💬
513 Data collection - - - - 1件: 65 💬
514 Decortin (prednisona) 5 mg comprimidos Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
515 Depot tetracosactide Tetracosactide 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 83 💬
516 Device: 129xe small and large human lung coil - - - - 1件: 299 💬
517 Device: 3he human lung coil - - - - 1件: 299 💬
518 Device: abatacept combination product (acp) Abatacept 1件: D03203 💬 2件: CD80, CD86 💬 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 1件: 46 💬
519 Device: abdominal compression - - - - 2件:  6 , 17 💬
520 Device: auto-titrating oxygen system Oxygen 1件: D00003 💬 - - 1件: 85 💬
521 Device: c-stem™ amt femoral component (standard and high off-set variants) - - - - 1件: 46 💬
522 Device: capacity of muscular oxygen extraction Oxygen 1件: D00003 💬 - - 1件: 13 💬
523 Device: cellvizio 100 series system with confocal miniprobes - - - - 1件: 215 💬
524 Device: cervical orthosis (co) - - - - 1件: 70 💬
525 Device: cobalt™ bone cement Cobalt - - - 1件: 46 💬
526 Device: continuous glucose monitor Dextrose, unspecified form - - - 1件: 65 💬
527 Device: continuous glucose monitor (cgm) Dextrose, unspecified form - - - 1件: 299 💬
528 Device: continuous glucose monitoring Dextrose, unspecified form - - - 2件: 75, 299 💬
529 Device: contrast enhanced ultrasound - - - - 1件: 96 💬
530 Device: conventional syringe - bd ref 309604 - - - - 1件: 46 💬
531 Device: cotton gauze with petrolatum Cotton 2件: D05304, D05331 💬 - - 2件: 35, 162 💬
532 Device: fourier domain doppler optical coherence tomography (fdoct) - - - - 1件: 13 💬
533 Device: high flow nasal oxygen cannula Oxygen 1件: D00003 💬 - - 1件: 299 💬
534 Device: high-resolution peripheral quantitative computed tomography (hr-pqct) - - - - 1件: 46 💬
535 Device: hyperbaric oxygen Oxygen 1件: D00003 💬 - - 1件: 46 💬
536 Device: in utero endoscopic correction of myelomeningocele ide - laparotomy/uterine exteriorization technique - - - - 1件: 118 💬
537 Device: in utero endoscopic correction of myelomeningocele ide - percutaneous technique - - - - 1件: 118 💬
538 Device: intermittent exposure to oxygen via oro-nasal mask Oxygen 1件: D00003 💬 - - 1件: 226 💬
539 Device: light box ( litebook company) - - - - 1件:  6  💬
540 Device: light box (litebook company) - - - - 1件:  6  💬
541 Device: manual toothbrush and water flosser (philips sonicare airfloss) Water 1件: D00001 💬 - - 1件: 51 💬
542 Device: mri with contrast agent injection - - - - 1件: 19 💬
543 Device: mri without contrast agent injection - - - - 1件: 19 💬
544 Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation Oxygen 1件: D00003 💬 - - 1件: 299 💬
545 Device: optical coherence tomography (oct) - - - - 1件: 13 💬
546 Device: optical coherence tomography angiography (octa) - - - - 1件: 13 💬
547 Device: oxygen Oxygen 1件: D00003 💬 - - 1件: 299 💬
548 Device: oxygen saturation Oxygen 1件: D00003 💬 - - 1件: 84 💬
549 Device: oxymizer® compared to cnc - - - - 1件: 85 💬
550 Device: pfp and sf6 human lung coil - - - - 1件: 299 💬
551 Device: sham compression - - - - 2件:  6 , 17 💬
552 Device: sonic toothbrush (philips sonicare) and water flosser (philips sonicare airfloss) Water 1件: D00001 💬 - - 1件: 51 💬
553 Device: standard oxygen therapy/ra Oxygen 1件: D00003 💬 - - 1件: 299 💬
554 Device: the colonic transendoscopic enteral tubing. - - - - 1件: 97 💬
555 Device: voluntary peak cough flow testing - - - - 1件:  2  💬
556 Dexamethasone (50mg 1dd6, 3 consecutive days/month) Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 35 💬
557 Dextrose, 5% in water Dextrose, unspecified form 1件: D00001 💬 - - 1件: 65 💬
558 Diagnostic test: adalimumab serum trough concentration Adalimumab 1件: D02597 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
559 Diagnostic test: adalimumab trough concentration Adalimumab 1件: D02597 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
560 Diagnostic test: blood drawing in healthy controls - - - - 1件: 65 💬
561 Diagnostic test: colchicine level measurement Colchicine 1件: D00570 💬 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 1件: 266 💬
562 Diagnostic test: colonoscopy - - - - 1件: 97 💬
563 Diagnostic test: continuous glucose monitoring Dextrose, unspecified form - - - 1件: 299 💬
564 Diagnostic test: cosyntropin stimulation test Tetracosactide 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 83 💬
565 Diagnostic test: fibrinogen plasma concentration, coagulation factor xiii activity Factor XIII (human) - - - 1件: 288 💬
566 Diagnostic test: maximum oxygen uptake Oxygen 1件: D00003 💬 - - 1件: 294 💬
567 Diagnostic test: mini cognitive examination (mce) - - - - 1件:  6  💬
568 Diagnostic test: ocular coherence tomography-angiography (oct-a) - - - - 2件: 90, 301 💬
569 Diagnostic test: p-mpa concentration - - - - 1件: 51 💬
570 Diagnostic test: parasitological diagnostics (coproscopy) - - - - 1件: 97 💬
571 Diagnostic test: rey-osterrieth complex figure test (rocft) - - - - 1件:  6  💬
572 Diagnostic test: serum metal ion levels determined to monitor changes in chromium and cobalt levels Chromium - - - 1件: 46 💬
573 Diagnostic test: simultaneous combined 18f-fdg pet and cardiac mri imaging Fludeoxyglucose (18F) - - - 1件: 84 💬
574 Diagnostic test: spanish-complutense verbal learning test (tavec) - - - - 1件:  6  💬
575 Diazoxide choline controlled-release tablet Choline 2件: D00294, D07690 💬 2件: ABCC8, KCNJ11 💬 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 1件: 193 💬
576 Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon Ammonium chloride 1件: D01139 💬 - - 1件: 96 💬
577 Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias) Amiodarone 2件: D00636, D02910 💬 16件: ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 31件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 28 💬
578 Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus egcg Amiodarone 2件: D00636, D02910 💬 16件: ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 31件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 28 💬
579 Dmso cocktail Dimethyl sulfoxide 1件: D01043 💬 - - 1件: 226 💬
580 Dmt continuation - - - - 1件: 13 💬
581 Doptelet 20 mg film-coated tablets - - - - 1件: 63 💬
582 Drug free, is monotherapy and gc combined with is - - - - 1件: 300 💬
583 Dual release hydrocortisone (plenadren) Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
584 E. coli nissle - - - - 1件: 97 💬
585 Echo and myocardial contrast echocardiography perfusion imaging - - - - 1件: 58 💬
586 Eflornithine plus nifurtimox combination therapy Eflornithine 2件: D00833, D07883 💬 1件: ODC1 💬 3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 1件: 65 💬
587 Eltrombopag combining rituximab Eltrombopag 2件: D02994, D03978 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 63 💬
588 Enalapril and other angiotensin converting enzyme inhibitors Angiotensin II 4件: D00150, D00621, D02014, D07892 💬 3件: ACE, AGTR1, AGTR2 💬 18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 19 💬
589 Endoprost - 0.05 mg/0.5 ml concentrato per soluzione per infusione 1 fiala - - - - 1件: 51 💬
590 Entacapone Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 2件:  6 , 17 💬
591 Entacapone 400mg oral dose Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 2件:  6 , 17 💬
592 Entacapone and carbidopa Carbidopa 2件: D00558, D00781 💬 2件: COMT, DDC 💬 10件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
593 Entacapone inn Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 1件:  6  💬
594 Enteric coated mycophenolate sodium Mycophenolic acid 1件: D05096 💬 2件: IMPDH1, IMPDH2 💬 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 1件: 228 💬
595 Enteric-coated mycophenolate sodium Mycophenolic acid 1件: D05096 💬 2件: IMPDH1, IMPDH2 💬 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 1件: 49 💬
596 Epilim chrono 200 controlled released tablets - - - - 1件: 256 💬
597 Epilim chrono 300 controlled released tablets - - - - 1件: 256 💬
598 Epilim chrono 500 controlled released tablets - - - - 1件: 256 💬
599 Epinephrine Epinephrine 3件: D00095, D00996, D02149 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件: 46, 96 💬
600 Etanercept, methotrexate, prednisolone Etanercept 11件: D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬 5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬 70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 56 💬
601 Etims (edc-fixed autologous pbmcs coupled with 7 immunodominant myelin peptides in ms patients) - - - - 1件: 13 💬
602 Ev substance code: sub188638 - - - - 1件: 113 💬
603 Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length lamb3 cdna. - - - - 1件: 36 💬
604 Experimental glatiramer acetate Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
605 Extension cohort - - - - 1件: 60 💬
606 Ezetimibe+simvastatin drug combination Ezetimibe 2件: D00434, D01966 💬 2件: HMGCR, NPC1L1 💬 5件: AMPK signaling pathway, Bile secretion, Fat digestion and absorption, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 49 💬
607 Fabrazyme - 35 mg polvere per concentrato per soluzione per infusione endovenosa 1 flaconcino - - - - 1件: 19 💬
608 Factor viii concentrate Beroctocog alfa - - - 1件: 288 💬
609 Factor xiii concentrate (human) Factor XIII (human) - - - 1件: 288 💬
610 Factor xiii concentrate (human), pasteurized Factor XIII (human) - - - 1件: 288 💬
611 Fampyra - 10 mg - compressa a rilascio prolungato - uso orale - flacone (hdpe) 56 compresse (4 flaconi da 14) - - - - 1件: 13 💬
612 Fdl176 & fdl169 coadministration - - - - 1件: 299 💬
613 Fenfluramine hydrochloride (colorless) Fenfluramine 1件: D07945 💬 4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 2件: 140, 144 💬
614 Ferinject or cosmofer - - - - 1件: 86 💬
615 Fibrinogen (coagulation factori) Fibrinogen human - - - 1件: 65 💬
616 Fibrinogen concentrate Fibrinogen human - - - 1件: 14 💬
617 Fibrinogen concentrate from human plasma Fibrinogen human - - - 1件: 65 💬
618 Fibrogammin®p, coagulation factor xiii concentrate (human) Factor XIII (human) - - - 1件: 51 💬
619 Film-coated tablet - - - - 1件: 97 💬
620 Fipamezole odt cohort 2 Fipamezole - - - 1件:  6  💬
621 Firdapse - 10 mg - compresse - uso orale - blister(alu/pvc/pvdc) 100 x 1 compresse - - - - 1件: 11 💬
622 Fish oil concentrate Fish oil - - - 1件: 13 💬
623 Fixed dose combination ciprofloxacin/celecoxib Celecoxib 3件: D00186, D00567, D02216 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件:  2  💬
624 Flaxseed lignan-enriched complex (flc) - - - - 1件: 97 💬
625 Fludarabina accord - 25 mg/ml concentrato per soluzione iniettabile o per infusione 5 flaconcini in vetro da 2 ml Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 19 💬
626 Fludarabina teva - 25 mg/ml concentrato per soluzione iniettabile o per infusione 1 flaconcino di vetro da 2 ml Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 65 💬
627 Formistin - 10 mg compresse rivestite con film 20 compresse - - - - 1件: 13 💬
628 Fostamatinib 50 mg blue film-coated tablet Fostamatinib 1件: D09347 💬 1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 1件: 46 💬
629 Fxiii concentrate (human) - - - - 1件: 288 💬
630 Fxiii concentrate (human) (fxiii) - - - - 1件: 288 💬
631 G-csf for conditioning before hsct. Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件: 65 💬
632 Gaboxadol monohydrate 0.5 mg (intended commercial formulation) Gaboxadol 1件: D04282 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件: 201 💬
633 Gaboxadol monohydrate 2 mg (intended commercial formulation) Gaboxadol 1件: D04282 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件: 201 💬
634 Gaboxadol monohydrate 5 mg (intended commercial formulation) Gaboxadol 1件: D04282 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件: 201 💬
635 Gadolinium contrast Gadolinium - - - 1件: 34 💬
636 Gadolinium-based contrast Gadolinium - - - 1件: 13 💬
637 Gelatin Gelatin 2件: D00115, D06892 💬 - - 4件: 28, 78, 97, 269 💬
638 General corticotherapy - - - - 1件: 35 💬
639 Genetic: amplification by pcr and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene - - - - 1件: 265 💬
640 Genetic: blood or saliva sample collection - - - - 1件: 299 💬
641 Genetic: recombinant adenovirus containing the ornithine transcarbamylase gene Ornithine 1件: D08302 💬 - - 1件: 251 💬
642 Genetically corrected cultured epidermal autograft (atmp) - - - - 1件: 36 💬
643 Genotropin (somatropin) is a growth hormone treatment. it is an exact copy of the natural growth hormone that our bodies make. the main difference is that genotropin is man-made. Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 193 💬
644 Glatiramer Glatiramer 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 4件:  2 , 13, 96, 156 💬
645 Glatiramer acetate Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 3件: 13, 96, 156 💬
646 Glatiramer acetate (copaxone®) Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 2件: 13, 156 💬
647 Glatiramer acetate (db) Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
648 Glatiramer acetate (ga) Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
649 Glatiramer acetate (ga) 40 mg Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
650 Glatiramer acetate (gtr) Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
651 Glatiramer acetate (ol) Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
652 Glatiramer acetate 150mg enteric coated tablets Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
653 Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
654 Glatiramer acetate 20 mg Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
655 Glatiramer acetate 20 mg, with mitoxantrone Acetate 3件: D02166, D04318, D08224 💬 22件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, TOP2A, TOP2B 💬 33件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Platinum drug resistance, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
656 Glatiramer acetate 20 mg/0.5 ml Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
657 Glatiramer acetate 40 mg Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
658 Glatiramer acetate [ga] Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
659 Glatiramer acetate injection with oral cetirizine hydrochloride Acetate 3件: D00664, D04318, D07662 💬 21件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, HRH1 💬 35件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
660 Glatiramer acetate with minocycline Acetate 3件: D00850, D04318, D05045 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
661 Glatiramer acetate, (copaxone®) Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
662 Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
663 Glatiramer acetate, n-acetylcysteine Acetate 2件: D00221, D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
664 Glatiramer acetato Glatiramer 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
665 Glivec 100 mg comprimidos recubiertos con película - - - - 2件: 34, 86 💬
666 Glivec 400 mg comprimidos recubiertos con película - - - - 1件: 34 💬
667 Glucocorticoid (prednisone or prednisolone) Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
668 Gm-csf (granulocyte-macrophage colony-stimulating factor, sargramostim) Sargramostim 1件: D05803 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 1件: 229 💬
669 Granulocyte - colony stimulating factor (g-csf) Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件:  2  💬
670 Granulocyte colony stimulating factor Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 6件:  2 , 28, 36, 57, 65, 85 💬
671 Granulocyte colony stimulating factor (g-csf) Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件: 65 💬
672 Granulocyte colony stimulating factor (gcsf) Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 2件: 36, 57 💬
673 Granulocyte colony-stimulating factor - - - - 1件: 296 💬
674 Granulocyte colony-stimulating factor (filgrastim) Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件: 113 💬
675 Granulocyte-colony stimulating factor (g-csf) and prednisone Filgrastim 2件: D00473, D03235 💬 2件: CSF3R, NR3C1 💬 6件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer 1件: 13 💬
676 Granulocyte-macrophage colony stimulating factor (gm-csf) - - - - 1件: 229 💬
677 Granulocyte-macrophage colony-stimulating factor (gm-csf) - - - - 1件: 11 💬
678 Group 1- control diet - - - - 1件: 97 💬
679 Growth colony stimulating factor (g-csf) Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件: 49 💬
680 Gsk1265744b (sodium salt) containing 14c-gsk1265744b - - - - 1件: 265 💬
681 H.p. acthar gel (repository corticotropin injection) Corticotropin 1件: D00146 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 13 💬
682 Haemate p® (human coagulation factor viii) Antihemophilic factor human - - - 1件: 288 💬
683 Haplo/cord transplant - - - - 1件: 60 💬
684 Hcq/cq and cab combined treatment - - - - 1件: 74 💬
685 Helium / oxygen mixed gas inhalation therapy Helium 2件: D00003, D04420 💬 - - 1件: 330 💬
686 Heparin & alkalinized lidocaine bladder instillation Heparin 4件: D00358, D02086, D07510, D08127 💬 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 1件: 226 💬
687 High dose vehicle control - - - - 1件: 46 💬
688 High water intake Water 1件: D00001 💬 - - 1件: 67 💬
689 Hiomega-3 supplement of naturalis® company - - - - - 1件: 49 💬
690 Histamine Histamine 1件: D08040 💬 4件: HRH1, HRH2, HRH3, HRH4 💬 4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 1件: 13 💬
691 Hmg-coenzyme inhibitor (statin) - - - - 1件: 218 💬
692 Hov-12020 (palm tocotrienols complex) - - - - 1件: 124 💬
693 Human coagulation factor viii Antihemophilic factor human - - - 1件: 288 💬
694 Human coagulation factor viii / von willebrand factor Antihemophilic factor human - - - 1件: 288 💬
695 Human coagulation factor viii associated with von willebrand factor (vwf) Antihemophilic factor human - - - 1件: 288 💬
696 Human coagulation factor viii, von willebrand factor complex Antihemophilic factor human - - - 1件: 288 💬
697 Human fibrinogen concentrate Fibrinogen human - - - 1件: 65 💬
698 Human interferon beta-1a and glatiramer acetate Acetate 2件: D04318, D04554 💬 22件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, IFNAR1, IFNAR2 💬 44件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
699 Human monoclonal antibody directed against complement 5 protein - - - - 1件: 62 💬
700 Human umbilical cord blood-derived mesenchymal stem cells - - - - 1件: 36 💬
701 Human umbilical cord derived msc transplantation for sle - - - - 1件: 49 💬
702 Human umbilical cord mesenchymal stem cells Human Umbilical Cord Mesenchymal Stem Cells - - - 2件: 13, 113 💬
703 Human umbilical cord-derived mscs - - - - 1件: 271 💬
704 Human von willebrand factor (vwf) and coagulation factor viii (fviii) Beroctocog alfa - - - 1件: 288 💬
705 Human vwf/fviii concentrate - - - - 1件: 288 💬
706 Hydrocortisone Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 9件:  6 , 46, 53, 75, 78, 81, 83, 97, 299 💬
707 Hydrocortisone (solucortef) Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
708 Hydrocortisone 100mg/ml Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 83 💬
709 Hydrocortisone 10mg Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
710 Hydrocortisone 10mg tablet Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
711 Hydrocortisone 10mg tablets Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
712 Hydrocortisone 20mg tablets Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
713 Hydrocortisone acetate Acetate 2件: D00088, D00165 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
714 Hydrocortisone cream Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
715 Hydrocortisone cream 1% Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
716 Hydrocortisone cream 10mg/g fna fagron Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
717 Hydrocortisone hydrogen succinate Hydrocortisone 2件: D00088, D01442 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 83 💬
718 Hydrocortisone modified release capsules Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
719 Hydrocortisone roussel Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 83 💬
720 Hydrocortisone sodium acetate Acetate 2件: D00088, D01779 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
721 Hydrocortisone sodium phosphate Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 53, 81, 83 💬
722 Hydrocortisone sodium succinate Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 81, 83, 97 💬
723 Hydrocortisone tablet 2.5 mg Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
724 Hydrocortisone takeda, tabletter Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 78 💬
725 Hyperglycemic clamp with concurrent gip infusion - - - - 1件: 299 💬
726 Hyperglycemic clamp with concurrent glp-1 infusion - - - - 1件: 299 💬
727 Hyperpolarized 129 xenon gas comparing idiopathic pulmonary fibrosis (ipf) treatment Xenon 2件: D01901, D06339 💬 - - 1件: 85 💬
728 Ic cocktail - - - - 1件: 226 💬
729 Idebenone 150 mg film-coated tablets Idebenone 1件: D01750 💬 - - 1件: 113 💬
730 Immunosuppression only conditioning (ioc) - - - - 1件: 65 💬
731 Immunosuppression only conditioning - closed with amendment l - - - - 1件: 65 💬
732 Inflectra 100 mg powder for concentrate for solution for infusion - - - - 2件: 96, 97 💬
733 Infliximab and azathioprine combination at week 0 Azathioprine 3件: D00238, D02598, D03033 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 96 💬
734 Infliximab and azathioprine combination at week 14 Azathioprine 3件: D00238, D02598, D03033 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 96 💬
735 Infliximab control Infliximab 1件: D02598 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
736 Inhibace/cozaar - - - - 1件: 66 💬
737 Injection of umbilical cord derived mscs - - - - 1件:  6  💬
738 Inn colecalciferol Cholecalciferol 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件: 13 💬
739 Intra-articular compound betamethasone Betamethasone 7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
740 Intraarticular morphine Morphine 3件: D00842, D02271, D08233 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 46 💬
741 Intravenous methyl prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 43 💬
742 Iron sucrose Iron sucrose 2件: D00025, D04616 💬 - - 3件: 62, 96, 97 💬
743 Iron sulphate 200mg coated tablets Iron - - - 2件: 96, 97 💬
744 Iron(iii)- hydroxide dextran complex Dextran 1件: D00060 💬 - - 2件: 96, 97 💬
745 Isotonic sodium chloride solution Chloride ion 1件: D02056 💬 - - 1件: 34 💬
746 Iv corticosteroid - - - - 1件: 97 💬
747 Jinarc - 15 mg +45 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28x15 mg + 28 x 45 mg) - - - - 1件: 67 💬
748 Jinarc - 15 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse - - - - 1件: 67 💬
749 Jinarc - 30 mg + 60 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 60 mg) - - - - 1件: 67 💬
750 Jinarc - 30 mg +90 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 90 mg) - - - - 1件: 67 💬
751 Jinarc - 30 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse - - - - 1件: 67 💬
752 Jnj-38518168-zbq - film-coated tablet - 10 mg - - - - 1件: 46 💬
753 Jnj-38518168-zbq - film-coated tablet - 10mg - - - - 1件: 46 💬
754 Jnj-38518168-zbq - film-coated tablet - 3 mg - - - - 1件: 46 💬
755 Jnj-38518168-zbq - film-coated tablet - 30 mg - - - - 1件: 46 💬
756 Jnj-38518168-zbq - film-coated tablet - 30mg - - - - 1件: 46 💬
757 Jnj-38518168-zbq - film-coated tablet - 3mg - - - - 1件: 46 💬
758 Jnj-39758979-aac - enteric coated tablet - 10 mg - - - - 1件: 46 💬
759 Jnj-39758979-aac - enteric coated tablet - 100 mg - - - - 1件: 46 💬
760 Jnj-39758979-aac - enteric coated tablet - 30 mg - - - - 1件: 46 💬
761 Kalydeco 150 mg film-coated tablets - - - - 1件: 299 💬
762 Kvd900 100 mg film coated tablet - - - - 1件: 65 💬
763 L01x co2 - - - - 1件: 46 💬
764 L04aa04 - immunoglobulina antitimocitaria (di coniglio) immunoglobulina di coniglio antitimociti umani thymoglobuline Antithymocyte immunoglobulin (rabbit) - - - 1件: 13 💬
765 Lactose in water Lactose 3件: D00001, D00046, D03226 💬 - - 1件: 97 💬
766 Lap tap bupivacaine/epinephrine Bupivacaine 5件: D00095, D00996, D01450, D02149, D07552 💬 14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 96 💬
767 Lentiviral vector containing abca4 gene - - - - 1件: 301 💬
768 Lentiviral vector containing myo7a gene - - - - 2件: 90, 303 💬
769 Lentiviral vector containing the human my07a gene - - - - 2件: 90, 303 💬
770 Levodopa cr (controlled release) Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
771 Levodopa, carbidopa, entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
772 Levodopa, decarboxylase inhibitor and comt inhibitor Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
773 Levodopa-carbidopa-entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
774 Levodopa/carbidopa/entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
775 Lidocaine Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 10件:  6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬
776 Lidocaine 1% injectable solution Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 34 💬
777 Lidocaine 2% without vessel constrictor Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 51 💬
778 Lidocaine injection 2% Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 168 💬
779 Lidocaine patch 5% Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 13 💬
780 Lidocaine releasing intravesical system - liris® Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 226 💬
781 Linaclotide Linaclotide 1件: D09355 💬 1件: GUCY2C 💬 2件: Metabolic pathways, Purine metabolism 1件: 97 💬
782 Lipasa ácida lisosómica, esterasa, colesterol (gen humano lipa), lipasa ácida lisosómica (gen humano lipa) - - - - 1件: 19 💬
783 Lisinopril, losartan, and atorvastatin Atorvastatin 7件: D00258, D00357, D00362, D00887, D07474, D08131, D08146 💬 3件: ACE, AGTR1, HMGCR 💬 22件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 222 💬
784 Lo-ovral oral contraceptive pills - - - - 1件: 60 💬
785 Local anesthesia (lidocaine hydrochloride) Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件:  6  💬
786 Locally approved intravenous contrast medium for contrast enhanced mri - - - - 1件: 13 💬
787 Lodotra (delayed release prednisolone) Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 41 💬
788 Long-circulating liposomal prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
789 Losartan Losartan 2件: D00357, D08146 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
790 Losartan and atenolol or propranolol Atenolol 5件: D00235, D00357, D00483, D08146, D08443 💬 4件: ADRB1, ADRB2, ADRB3, AGTR1 💬 22件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 167 💬
791 Losartan and nebivolol Losartan 3件: D00357, D05127, D08146 💬 2件: ADRB1, AGTR1 💬 21件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 167 💬
792 Losartan and other angiotensin receptor blockers Angiotensin II 4件: D00150, D00357, D02014, D08146 💬 2件: AGTR1, AGTR2 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 19 💬
793 Losartan bluefish 50 mg Bluefish 2件: D00357, D08146 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 58 💬
794 Losartan hexal Losartan 2件: D00357, D08146 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 36 💬
795 Losartan potasico Losartan 2件: D00357, D08146 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 179 💬
796 Losartan potassium Losartan 3件: D00357, D08146, D08403 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 5件: 36, 98, 167, 179, 215 💬
797 Losartan tablets & qingremoshen granule Losartan 2件: D00357, D08146 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 222 💬
798 Low antigen content diet - - - - 1件: 66 💬
799 Low dose prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
800 Low dose vehicle control - - - - 1件: 46 💬
801 Lum/iva fixed-dose combination - - - - 1件: 299 💬
802 Lumacaftor plus ivacaftor combination Ivacaftor 2件: D09916, D10134 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 1件: 299 💬
803 Lumacaftor, ivacaftor drug combination Ivacaftor 2件: D09916, D10134 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 1件: 299 💬
804 Lzrse-col7a1 engineered autologous epidermal sheets - - - - 1件: 36 💬
805 Mabcampath 10 mg/ml concentrado para solución para perfusión - - - - 1件: 13 💬
806 Mabthera 100 mg concentrate for solution for infusion - - - - 1件: 222 💬
807 Mabthera 500 mg (10 mg/ml) concentrate for solution for infusion - - - - 1件: 46 💬
808 Mabthera 500 mg concentrado para solución para perfusión - - - - 1件: 46 💬
809 Mabthera 500 mg concentrate for solution for infusion - - - - 2件: 46, 222 💬
810 Mabthera®, 100 mg concentrado para solución para perfusión - - - - 1件: 46 💬
811 Mabthera®, 100 mg concentrate for solution for infusion - - - - 1件: 46 💬
812 Magnesium sulfate Magnesium 1件: D01108 💬 - - 3件: 11, 296, 297 💬
813 Marketed plasma-derived vwf/fviii concentrate - - - - 1件: 288 💬
814 Medical air vs oxygen Medical air 1件: D00003 💬 - - 1件: 193 💬
815 Medical grade oxygen Oxygen 1件: D00003 💬 - - 1件: 299 💬
816 Medium dose prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
817 Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) - - - - 1件: 13 💬
818 Mesalazine with hydrocortisone sodium succinate Hydrocortisone 2件: D00088, D00377 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
819 Metabolic cofactor supplementation - - - - 1件:  6  💬
820 Metformina - 500 30 compresse 500 mg Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 1件: 113 💬
821 Methotrexate - etanercept - prednisolone arm Etanercept 11件: D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬 5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬 70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
822 Methyl prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 43, 49, 96 💬
823 Methylphenidate Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 7件:  6 , 13, 34, 84, 113, 179, 206 💬
824 Methylphenidate (mpd) Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件:  6  💬
825 Methylphenidate (overencapsulated) Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 84 💬
826 Methylphenidate 10mg tablets Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 84 💬
827 Methylphenidate hydrochloride Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 2件:  6 , 13 💬
828 Methylphenidate modified release Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 13 💬
829 Methylphenidate modified release 20 mg Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 13 💬
830 Methylphenidate modified release 30 mg Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 13 💬
831 Methylphenidate modified release 40 mg Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 13 💬
832 Methylphenidate, fluoxetin, risperidone Fluoxetine 5件: D00326, D00426, D00823, D01296, D04999 💬 5件: DRD2, HTR2A, SLC6A2, SLC6A3, SLC6A4 💬 14件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 2件: 179, 206 💬
833 Methylprednisolone or prednisolone Methylprednisolone 14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 65 💬
834 Metoclopramide accord - 10 mg compresse 28 compresse in blister pvc/pvdc/al Metoclopramide 3件: D00726, D02213, D05008 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件: 51 💬
835 Metopirone 250 mg capsules/cormeto - - - - 1件: 75 💬
836 Metotrexato sandoz - 2.5 mg compresse 50 compresse in flacone pp Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 46 💬
837 Metotrexato-lederle 2,5 mg comprimidos Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 46 💬
838 Microgynon® 30 (oral contraceptive) - - - - 1件: 46 💬
839 Minocycline 100 mg film-coated tablets Minocycline 2件: D00850, D05045 💬 - - 1件: 13 💬
840 Modified cobratoxin - - - - 1件: 20 💬
841 Morphine Morphine 3件: D00842, D02271, D08233 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 5件: 36, 46, 70, 85, 86 💬
842 Morphine hexal Morphine 3件: D00842, D02271, D08233 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 46 💬
843 Morphine hydrochloride Morphine 3件: D00842, D02271, D08233 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 85 💬
844 Morphine pca Morphine 3件: D00842, D02271, D08233 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 70 💬
845 Morphine sulfate Morphine 3件: D00842, D02271, D08233 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 3件: 46, 85, 86 💬
846 Morphine sulphate in intrasite gel Morphine 3件: D00842, D02271, D08233 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 36 💬
847 Myeloablative conditioning regimen - - - - 1件: 164 💬
848 Myeloablative conditioning-closed with amendment l - - - - 1件: 65 💬
849 Myozyme 50 mg powder for concentrate for solution for infusion - - - - 1件: 256 💬
850 Méthotrexate bellon comprimé Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 271 💬
851 Nebulized combination ipratropium bromide with salbutamol Ipratropium 2件: D02147, D02212 💬 6件: ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 17件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
852 Neoral soft gelatin capsules Gelatin 2件: D00115, D06892 💬 - - 2件: 97, 269 💬
853 Nerixia*infus iv conc 2f 100mg - - - - 1件: 274 💬
854 Nifurtimox-eflronithine combination treatment (nect) Nifurtimox 1件: D00833 💬 - - 1件: 65 💬
855 Nitisinone 10 mg tablet high compritol Nitisinone 1件: D05177 💬 1件: HPD 💬 5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 1件: 241 💬
856 Nitric oxide plus oxygen Nitric Oxide 2件: D00003, D00074 💬 - - 1件: 86 💬
857 Non atg conditioning regimen - - - - 1件: 60 💬
858 Norvir 100 mg film-coated tablets - - - - 1件: 299 💬
859 Novartis pharmaceuticals corporation - - - - 1件: 13 💬
860 Nutraceutical combination - - - - 1件: 96 💬
861 Nutritional formulation containing exogenous ketones - - - - 1件: 201 💬
862 Ondansetron 8 mg film-coated tablets Ondansetron 2件: D00456, D00678 💬 5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 2件: Serotonergic synapse, Taste transduction 1件:  6  💬
863 Optivate® (human coagulation factor viii) Antihemophilic factor human - - - 1件: 288 💬
864 Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone Mesalazine 7件: D00377, D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
865 Oral bovine type i collagen Bovine type I collagen - - - 1件: 51 💬
866 Oral bovine type ii collagen - - - - 1件: 46 💬
867 Oral ciprofloxacin plus inhaled colistin Ciprofloxacin 4件: D00186, D02138, D02216, D07746 💬 - - 1件: 299 💬
868 Oral corticosteroids - - - - 3件: 13, 46, 97 💬
869 Oral corticosteroids (ocs) - - - - 1件: 162 💬
870 Oral prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 49, 145 💬
871 Orencia 250 mg polvo para concentrado para sol. para perfusión - - - - 1件: 46 💬
872 Orencia 250mg powder for concentrate for solution for infusion - - - - 1件: 46 💬
873 Orkambi 100 mg/125 mg film-coated tablets - - - - 1件: 299 💬
874 Orkambi 200 mg/125 mg film-coated tablets - - - - 1件: 299 💬
875 Orkambi: contains lumacaftor and ivacaftor Ivacaftor 2件: D09916, D10134 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 1件: 299 💬
876 Other cox-2 inhibitor - - - - 1件: 271 💬
877 Other cox-2 inhibitors - - - - 1件: 271 💬
878 Other: 0.9% sodium chloride Chloride ion 1件: D02056 💬 - - 1件: 65 💬
879 Other: 0.9ml sodium chloride Chloride ion 1件: D02056 💬 - - 1件: 271 💬
880 Other: 60% oxygen Oxygen 1件: D00003 💬 - - 1件: 85 💬
881 Other: abdominal compression - - - - 1件: 17 💬
882 Other: ad libitum water intake Water 1件: D00001 💬 - - 1件: 67 💬
883 Other: air - oxygen Oxygen 1件: D00003 💬 - - 1件: 299 💬
884 Other: assessment of medication compliance - - - - 1件: 98 💬
885 Other: blood collection for measurement of eculizumab peak concentrations Eculizumab 1件: D03940 💬 1件: C5 💬 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 1件: 62 💬
886 Other: blood sample and cotton skin swabs Cotton - - - 1件: 162 💬
887 Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (arterial blood gas and metabolic panel) and data collection from psg study. - - - - 1件: 230 💬
888 Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (venous blood gas and metabolic panel) and data collection from psg study. - - - - 1件: 230 💬
889 Other: cawthorne cooksey exercises - - - - 1件: 13 💬
890 Other: coa-z - - - - 1件: 120 💬
891 Other: coaching sessions - - - - 1件: 49 💬
892 Other: coduse balance training and step square exercises Isoxaflutole - - - 1件: 13 💬
893 Other: coffee - - - - 1件: 96 💬
894 Other: cognitive training - - - - 1件: 206 💬
895 Other: colchicine cessation Colchicine 1件: D00570 💬 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 1件: 266 💬
896 Other: collection of csf, blood, urine, saliva - - - - 1件:  6  💬
897 Other: communicative effectiveness survey - - - - 1件:  2  💬
898 Other: comparator: cpet cycle ergometer (gold standard) Gold - - - 1件: 299 💬
899 Other: computer game based balance and walking rehabilitation for individuals with parkinson's disease Isoxaflutole - - - 1件:  6  💬
900 Other: concomitant medication - - - - 1件: 49 💬
901 Other: continuation of dornase alfa (dnase) Dornase alfa 1件: D03896 💬 - - 1件: 299 💬
902 Other: continuation of hypertonic saline (hs) - - - - 1件: 299 💬
903 Other: continue their usual therapy - - - - 1件: 66 💬
904 Other: control - - - - 8件:  6 , 19, 70, 75, 85, 97, 162, 193 💬
905 Other: control diet - - - - 1件: 96 💬
906 Other: control group - - - - 1件:  2  💬
907 Other: control group(normal saline) - - - - 1件: 97 💬
908 Other: control wound treatment - - - - 1件: 36 💬
909 Other: controlled environment tests (series of tasks of everyday life) - - - - 1件:  6  💬
910 Other: controls primary cervical dystonia (trihexyphenidyl) Trihexyphenidyl 2件: D00787, D08638 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
911 Other: conventional balance training Isoxaflutole - - - 1件: 13 💬
912 Other: conventional drugs - - - - 1件: 97 💬
913 Other: conventional pca mode - - - - 1件: 70 💬
914 Other: core stability - - - - 1件: 13 💬
915 Other: corn starch Starch, corn 1件: D05297 💬 - - 1件: 49 💬
916 Other: corticotropin releasing hormone (crh) Corticotropin 1件: D00146 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 78 💬
917 Other: cough monitor Methamidophos - - - 1件: 85 💬
918 Other: dead sea solar and water treatment Water 1件: D00001 💬 - - 1件: 46 💬
919 Other: dextrose water 5% Dextrose, unspecified form 1件: D00001 💬 - - 1件: 56 💬
920 Other: diary completion - - - - 1件:  6  💬
921 Other: dyt 1 dystonia (healthy control) - - - - 1件:  6  💬
922 Other: exercise followed cold water immersion Water 1件: D00001 💬 - - 1件: 46 💬
923 Other: group exercise: community setting - - - - 1件: 70 💬
924 Other: harkány medicinal water Water 1件: D00001 💬 - - 1件: 46 💬
925 Other: healthy controls - - - - 1件: 63 💬
926 Other: high resolution peripheral quantitative computed tomography (hrpqct) - - - - 1件: 172 💬
927 Other: high water intake Water 1件: D00001 💬 - - 1件: 67 💬
928 Other: histamine Histamine 1件: D08040 💬 4件: HRH1, HRH2, HRH3, HRH4 💬 4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 1件: 13 💬
929 Other: historical control - - - - 1件:  2  💬
930 Other: human umbilical cord-derived mscs and cyclosporin a Cyclosporine 1件: D00184 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 60 💬
931 Other: hydrocortisone Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 75 💬
932 Other: hyperbaric oxygen Oxygen 1件: D00003 💬 - - 1件: 96 💬
933 Other: hyperbaric oxygen therapy Oxygen 1件: D00003 💬 - - 2件: 97, 226 💬
934 Other: ibuprofen and isosorbide dinitrate combination Ibuprofen 6件: D00126, D00347, D00516, D01122, D04490, D06606 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 113 💬
935 Other: impact of biotherapy on postoperative morbidity in ulcerative colitis - - - - 1件: 97 💬
936 Other: iv steroids combination alone - - - - 1件: 41 💬
937 Other: leukapheresis- collection of stem cells - - - - 1件: 96 💬
938 Other: losartan Losartan 2件: D00357, D08146 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 46 💬
939 Other: low blood pressure control - - - - 1件: 67 💬
940 Other: medication compliance phone call - - - - 1件: 98 💬
941 Other: natural herbs of coconut, aloe vera, and pepperint Aloe Vera Leaf - - - 1件: 53 💬
942 Other: no msdmds therapy (control) - - - - 1件: 13 💬
943 Other: normal (control) diet - - - - 1件: 240 💬
944 Other: nutrition counseling - - - - 1件: 298 💬
945 Other: observational cohort - - - - 1件:  6  💬
946 Other: observational control - - - - 1件: 13 💬
947 Other: optional blood-oxygen-level dependent functionalmri Oxygen 1件: D00003 💬 - - 1件:  6  💬
948 Other: oxygen Oxygen 1件: D00003 💬 - - 1件: 85 💬
949 Other: oxygen (2liter/min) Oxygen 1件: D00003 💬 - - 1件: 85 💬
950 Other: oxygen (4liter/min) Oxygen 1件: D00003 💬 - - 1件: 85 💬
951 Other: oxygen - air Oxygen 1件: D00003 💬 - - 1件: 299 💬
952 Other: oxygen supplementation Oxygen 1件: D00003 💬 - - 1件: 86 💬
953 Other: pittsburgh compound b [11c]-pib Pittsburgh Compound B - - - 1件:  6  💬
954 Other: plasticity-based computerized cognitive remediation program - - - - 1件: 13 💬
955 Other: potable water Water 1件: D00001 💬 - - 1件: 19 💬
956 Other: reaction time and postural control - - - - 1件: 299 💬
957 Other: serum calcium concentrations results Calcium - - - 1件: 235 💬
958 Other: sham abdominal compression - - - - 1件: 17 💬
959 Other: sham comparator - - - - 1件: 299 💬
960 Other: sham-procedure (dose cohort 1&2 only) - - - - 2件: 90, 303 💬
961 Other: sodium chloride Chloride ion 1件: D02056 💬 - - 1件: 51 💬
962 Other: standard blood pressure control - - - - 1件: 67 💬
963 Other: technetium [tc-99m] sulfur colloid and indium [in-111] dtpa Indium 1件: D05422 💬 - - 1件: 299 💬
964 Other: the patients' parents have to complete the vineland ii adaptive behavior scales scoring, the sleep disturbance scale for children (sdsc) and horne & ostberg circadian typology questionnaire - - - - 1件: 149 💬
965 Other: ulcerative colitis diet - - - - 1件: 97 💬
966 Other: untreated cohort - - - - 1件: 85 💬
967 Other: voluntary cough test - - - - 1件:  6  💬
968 Other: water Water 1件: D00001 💬 - - 1件: 67 💬
969 Other: water prescription Water 1件: D00001 💬 - - 1件: 67 💬
970 Over the counter dha/epa dietary supplementation - - - - 1件: 301 💬
971 Over-encapsulated entacapone tablets Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 1件:  6  💬
972 Overencapsulated prednisolone tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
973 Ovine corticotropin-releasing hormone (ocrh) Corticorelin 2件: D00146, D03905 💬 3件: CRHR1, CRHR2, MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 75 💬
974 Oxycodone by patient-controlled analgesia (pca) Oxycodone 3件: D03783, D05312, D05462 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
975 Oxygen Oxygen 1件: D00003 💬 - - 18件:  6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬
976 Oxygen 40 % Oxygen 1件: D00003 💬 - - 1件: 85 💬
977 Oxygen supplementation Oxygen 1件: D00003 💬 - - 1件: 86 💬
978 Oxygen, liquid Oxygen 1件: D00003 💬 - - 2件: 86, 88 💬
979 Oxytocin (oxt) continuous Oxytocin 1件: D00089 💬 1件: OXTR 💬 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 1件: 193 💬
980 Pancrecarb® (pancrelipase) Pancrelipase 1件: D05349 💬 - - 1件: 299 💬
981 Pancrelipase Pancrelipase 1件: D05349 💬 - - 2件: 298, 299 💬
982 Pancrelipase amylase Pancrelipase 1件: D05349 💬 - - 1件: 299 💬
983 Pancrelipase delayed release Pancrelipase 1件: D05349 💬 - - 1件: 299 💬
984 Pancrelipase delayed release capsule Pancrelipase 1件: D05349 💬 - - 2件: 298, 299 💬
985 Pancrelipase microtablets Pancrelipase 1件: D05349 💬 - - 1件: 299 💬
986 Pancrelipase with bicarbonate Pancrelipase 1件: D05349 💬 - - 1件: 299 💬
987 Pancrelipase/pancreas powder Pancrelipase 1件: D05349 💬 - - 2件: 298, 299 💬
988 Paroxetine & prednisolone Paroxetine 12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬 2件: NR3C1, SLC6A4 💬 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件: 46 💬
989 Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp Paroxetine 12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬 2件: NR3C1, SLC6A4 💬 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件: 46 💬
990 Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp Paroxetine 12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬 2件: NR3C1, SLC6A4 💬 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件: 46 💬
991 Part 1, jm-010 component group a - - - - 1件:  6  💬
992 Part 1, jm-010 component group b - - - - 1件:  6  💬
993 Part 1, jm-010 component group c - - - - 1件:  6  💬
994 Part 2, jm-010 combination group a - - - - 1件:  6  💬
995 Part 2, jm-010 combination group b - - - - 1件:  6  💬
996 Part 2, jm-010 component group c - - - - 1件:  6  💬
997 Pct (purecell technologies complex) - - - - 1件: 97 💬
998 Peg-liposomal prednisolone sodium phosphate Phosphate ion 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 13, 97 💬
999 Pentasa compact 2g, granulate with prolonged release - - - - 1件: 97 💬
1000 Pentasa compact 4g, granulate with prolonged release - - - - 1件: 97 💬
1001 Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping - - - - 1件: 113 💬
1002 Perfluorinated gas/oxygen mixture Oxygen 1件: D00003 💬 - - 1件: 299 💬
1003 Ph-combination therapy - - - - 2件: 86, 88 💬
1004 Phase 1: conventiaonal dmard - - - - 1件: 46 💬
1005 Physiological serum (sodium chloride) Chloride ion 1件: D02056 💬 - - 1件: 193 💬
1006 Piperacillin-tazobactam combination product Piperacillin 4件: D00466, D00660, D02251, D08380 💬 - - 1件: 299 💬
1007 Pittsburgh compound b Pittsburgh Compound B - - - 2件:  6 , 127 💬
1008 Pittsburgh compound b (c-11 pib) Pittsburgh Compound B - - - 1件: 127 💬
1009 Pl 12185/0002 & pl 12185/0005(water for injection) Water 1件: D00001 💬 - - 1件: 57 💬
1010 Placental mesenchymal stem cells seeded on a commercially available dural graft extracellular matrix Placental Mesenchymal Stem Cells - - - 1件: 118 💬
1011 Plaquenil - hydroxychloroquine 200mg film coated tablets Hydroxychloroquine 1件: D08050 💬 - - 3件: 43, 44, 45 💬
1012 Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología prgf-system (bti) - - - - 1件: 96 💬
1013 Plasma-derived fviii/vwf concentrate - - - - 1件: 288 💬
1014 Plerixafor for conditioning before hsct. Plerixafor 1件: D08971 💬 1件: CXCR4 💬 12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 1件: 65 💬
1015 Pneumococcal conjugate vaccine - - - - 1件: 46 💬
1016 Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate Aluminium - - - 1件: 46 💬
1017 Prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
1018 Prednisolone & dipyridamole Dipyridamole 9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 3件: NR3C1, PDE4A, PDE5A 💬 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
1019 Prednisolone + mabthera Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 61 💬
1020 Prednisolone 1mg tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
1021 Prednisolone 2,5 mg tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
1022 Prednisolone 20 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
1023 Prednisolone 40 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
1024 Prednisolone 5 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 46, 51 💬
1025 Prednisolone 5 mg jenapharm Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 41 💬
1026 Prednisolone 5 mg tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
1027 Prednisolone 5mg gastro-resistant tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 51 💬
1028 Prednisolone 5mg tablet Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
1029 Prednisolone acetate Acetate 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 222 💬
1030 Prednisolone and chlorambucil Chlorambucil 9件: D00266, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 222 💬
1031 Prednisolone and mycophenolate mofetil Mycophenolate mofetil 12件: D00472, D00752, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05094, D05095, D05096 💬 3件: IMPDH1, IMPDH2, NR3C1 💬 4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 1件: 222 💬
1032 Prednisolone and taper Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 51 💬
1033 Prednisolone labesfal Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
1034 Prednisolone sodium metasulphobenzoate Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
1035 Prednisolone sodium phosphate Phosphate ion 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 13, 97 💬
1036 Prednisolone sodium succinate Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 95 💬
1037 Prednisolone tablets b.p. 5mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
1038 Prednisolone tablets bp Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
1039 Prednisolone tablets bp 1 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
1040 Prednisolone tablets usp 5 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
1041 Prednisolone-dipyridamole Dipyridamole 9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 3件: NR3C1, PDE4A, PDE5A 💬 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
1042 Prednisolone/prednisone Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 49 💬
1043 Prednisone + inhibace/cozaar Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
1044 Prednisone or prednisolone Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
1045 Prednisone/prednisolone Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 35 💬
1046 Probiotic capsules containing lactobacillus rhamnosus gr-1 and l. reuteri rc-14 - - - - 1件: 46 💬
1047 Procedure: 2 ml of whole blood sample will be collected on edta tube Edetic acid 8件: D00052, D00571, D01802, D03943, D03944, D03945, D03946, D03947 💬 - - 1件: 51 💬
1048 Procedure: 9% sodium chloride (nacl) iv Chloride ion 1件: D02056 💬 - - 1件: 78 💬
1049 Procedure: assessment of therapy complications - - - - 1件: 60 💬
1050 Procedure: biospecimen collection - - - - 1件: 159 💬
1051 Procedure: blood collection for pk testing (15 mins before injection) - - - - 1件: 46 💬
1052 Procedure: blood collection for pk testing (15 minutes post injection) - - - - 1件: 46 💬
1053 Procedure: blood collection for pk testing (18-20 hours post injection) - - - - 1件: 46 💬
1054 Procedure: blood collection for pk testing (180 minutes post injection) - - - - 1件: 46 💬
1055 Procedure: blood collection for pk testing (60 minutes post injection) - - - - 1件: 46 💬
1056 Procedure: blood collection for pk testing (after injection) - - - - 1件: 46 💬
1057 Procedure: blood sampling from umbilical cord - - - - 3件: 46, 96, 271 💬
1058 Procedure: bone marrow or umbilical cord blood (ucg) stem cell transplantation - - - - 1件: 36 💬
1059 Procedure: clobetasol propionate Clobetasol 2件: D01272, D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
1060 Procedure: colectomy - - - - 1件: 97 💬
1061 Procedure: collagenase Collagenase clostridium histolyticum 1件: D09596 💬 - - 1件: 162 💬
1062 Procedure: colonoscopy - - - - 1件: 97 💬
1063 Procedure: colorectal biopsies - - - - 1件: 97 💬
1064 Procedure: computed tomography - - - - 5件: 34, 40, 46, 49, 96 💬
1065 Procedure: continuous glucose monitoring system (cgms) Dextrose, unspecified form - - - 1件: 299 💬
1066 Procedure: continuous mononuclear cell collection (cmnc) - - - - 1件: 96 💬
1067 Procedure: contrast sensitivity measurement - - - - 1件: 19 💬
1068 Procedure: control group - - - - 1件: 34 💬
1069 Procedure: conventional surgery - - - - 1件: 34 💬
1070 Procedure: cord blood - - - - 1件: 60 💬
1071 Procedure: cord blood infusion - - - - 1件: 60 💬
1072 Procedure: coronary flow reserve se - - - - 3件: 58, 86, 215 💬
1073 Procedure: drug coated balloon (dcb) - - - - 1件: 40 💬
1074 Procedure: dynamic contrast-enhanced magnetic resonance imaging - - - - 1件: 13 💬
1075 Procedure: hydrocortisone withdrawal Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
1076 Procedure: hyperbaric oxygen Oxygen 1件: D00003 💬 - - 1件: 97 💬
1077 Procedure: hyperbaric oxygen therapy Oxygen 1件: D00003 💬 - - 1件: 90 💬
1078 Procedure: left ventricular contractile reserve se - - - - 3件: 58, 86, 215 💬
1079 Procedure: long term oxygen therapy Oxygen 1件: D00003 💬 - - 1件: 88 💬
1080 Procedure: management of therapy complications - - - - 2件: 28, 60 💬
1081 Procedure: mri imaging with intravenous contrast with gadoterate meglumine Gadoteric acid 2件: D01796, D08007 💬 - - 1件: 53 💬
1082 Procedure: non-myeloablative high dose immunosuppressive therapy conditioning (hdit) - - - - 1件: 49 💬
1083 Procedure: oxygen flow at the optic nerve head measurement Oxygen 1件: D00003 💬 - - 1件: 19 💬
1084 Procedure: single photon emission computed tomography - - - - 1件: 34 💬
1085 Procedure: sputum collection - - - - 1件: 299 💬
1086 Procedure: stem cell collection - - - - 1件: 28 💬
1087 Procedure: stem cell or umbilical cord blood transplantation - - - - 1件: 326 💬
1088 Procedure: supplemental oxygen via a mask Oxygen 1件: D00003 💬 - - 1件: 88 💬
1089 Procedure: umbilical cord blood therapy Umbilical Cord Blood Hematopoietic Stem Cells - - - 2件:  2 ,  6  💬
1090 Procedure: umbilical cord blood transplantation - - - - 5件: 60, 65, 284, 285, 326 💬
1091 Procedure: urinary collect - - - - 1件: 299 💬
1092 Procedure: urine collection - - - - 1件: 19 💬
1093 Procedure: warm compress prior to injection of glatiramer acetate Acetate 1件: D04318 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
1094 Procedure: water exercises Water 1件: D00001 💬 - - 1件: 46 💬
1095 Products containing aminosalicylate - - - - 1件: 97 💬
1096 Products containing azathioprine or 6-mercaptopurine Azathioprine 4件: D00161, D00238, D03033, D04931 💬 1件: HPRT1 💬 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 1件: 97 💬
1097 Prothrombin complex concentrate Factor IX Complex (Human) - - - 1件: 288 💬
1098 Ps188 (company code) - - - - 1件: 113 💬
1099 Pseudoephedrine + 480 ml water Pseudoephedrine 5件: D00001, D00485, D05648, D05649, D08449 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 17 💬
1100 Pseudoephedrine + 50 ml water Pseudoephedrine 5件: D00001, D00485, D05648, D05649, D08449 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 17 💬
1101 Ptc0161480, ptc124 compound 1a, rps2505, ptc-c124, 291844 - - - - 1件: 113 💬
1102 Pyridoxine plus prednisolone Prednisolone 10件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02179, D03301, D08454 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 145 💬
1103 Radiation: computed tomography lung subtraction iodine mapping Iodine 1件: D00108 💬 - - 1件: 88 💬
1104 Radiation: computerized tomography scan - - - - 1件: 98 💬
1105 Radiation: cone beam computed tomography (cbct) Tricyclazole - - - 1件: 51 💬
1106 Radiation: single photon emission computed tomography scans - - - - 1件: 98 💬
1107 Rapamune - 1 mg 100 compresse rivestite in blister uso orale - - - - 1件:  2  💬
1108 Rapamycin-calcitriol combination Calcitriol 2件: D00129, D00753 💬 2件: MTOR, VDR 💬 54件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway 1件: 158 💬
1109 Raxone - 150 mg- compresse rivestite con film- uso orale- flacone (hdpe)- 180 compresse - - - - 1件: 113 💬
1110 Recombinanat dna-derived human growth hormone produced in e.coli Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 78 💬
1111 Recombinant aav vector serotype 2 containing the human wild type mitochondrial nd4 gene - - - - 1件: 302 💬
1112 Recombinant adeno-associated viral vector serotype 2.7m8 containing the chrimsonr-tdtomato gene - - - - 1件: 90 💬
1113 Recombinant adeno-associated viral vector, serotype 2 (raav2/2) containing the human wild-type mitochondrial nadh dehydrogenase 4 gene (nd4) NADH - - - 1件: 302 💬
1114 Recombinant coagulation fviii fc – von willebrand factor – xten fusion protein Von Willebrand Factor Human - - - 1件: 288 💬
1115 Recombinant coagulation fviii fc – vonwillebrand factor – xten fusion protein - - - - 1件: 288 💬
1116 Recombinant dna-derived human growth hormone produced in e.coli Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 78 💬
1117 Recombinant granulocyte - colony stimulating factor - - - - 1件: 39 💬
1118 Recombinant human ?-glucosidase conjugated with synthetic bismannose-6-phosphate-man6 glycan Phosphate ion - - - 1件: 256 💬
1119 Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (neogaa) Avalglucosidase alfa 1件: D11744 💬 1件: GAA 💬 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 1件: 256 💬
1120 Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan avalglucosidase alfa (neogaa) Avalglucosidase alfa 1件: D11744 💬 1件: GAA 💬 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 1件: 256 💬
1121 Recombinant human angiotensin-converting enzyme 2 Angiotensin II 2件: D00150, D02014 💬 2件: AGTR1, AGTR2 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 86 💬
1122 Recombinant human angiotensin-converting enzyme 2 (ace2), apn01 Angiotensin II 2件: D00150, D02014 💬 2件: AGTR1, AGTR2 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 86 💬
1123 Recombinant human apolipoprotein a-i/phospholipids complex Omega-3 fatty acids - - - 1件: 79 💬
1124 Recombinant human coagulation factor viii fc - von willebrand factor - xten fusion protein Antihemophilic factor human - - - 1件: 288 💬
1125 Recombinant porcine coagulation factor viii (b domain deleted) Beroctocog alfa - - - 1件: 288 💬
1126 Recombinant porcine coagulation factor viii (b-domain deleted) Beroctocog alfa - - - 1件: 288 💬
1127 Reduced intensity conditioning - - - - 2件: 19, 65 💬
1128 Reduced intensity conditioning (ric) - - - - 1件: 65 💬
1129 Reduced intensity transplant conditioning - - - - 1件: 36 💬
1130 Regimen selection phase group 1 (completed) - - - - 1件: 113 💬
1131 Remicade 100 mg polvo para concentrado para solución para perfusión - - - - 2件: 46, 271 💬
1132 Remicade 100 mg powder for concentrate for solution for infusion. - - - - 2件: 96, 97 💬
1133 Remsima - 100 mg polvere per concentrato per soluzione per infusione - uso endovenoso - flanconcino (vetro) - 1 flaconcino - - - - 4件: 46, 96, 97, 271 💬
1134 Repository corticotropin injection Corticotropin 1件: D00146 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 5件:  2 , 13, 46, 84, 222 💬
1135 Repository corticotropin injection -treatment extension Corticotropin 1件: D00146 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 84 💬
1136 Revatio 20 mg film coated tablets - - - - 1件: 86 💬
1137 Revatio 20 mg film-coated tablets - - - - 1件: 86 💬
1138 Revatio 20 mg, comprimidos recubiertos con película - - - - 1件: 86 💬
1139 Revatio ® 20 mg film-coated tablets - - - - 1件: 86 💬
1140 Revolade 25 mg film-coated tablets - - - - 1件: 63 💬
1141 Revolade 50 mg film-coated tablets - - - - 1件: 63 💬
1142 Rhtpo in combination with rituximab Recombinant Human Thrombopoietin 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 63 💬
1143 Ribavirin Ribavirin 1件: D00423 💬 - - 2件:  2 , 96 💬
1144 Rifaximin delayed release 400 mg film coated tablet Rifaximin 1件: D02554 💬 - - 1件: 96 💬
1145 Rilutek 50 mg film-coated tablets - - - - 1件:  2  💬
1146 Rilutek 50 mg, film-coated tablets - - - - 1件:  2  💬
1147 Riluzolo teva - 50 mg compresse rivestite con film 90 compresse in blister al/pvc - - - - 1件: 114 💬
1148 Riociguat coated tablet 0.5 mg Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 51 💬
1149 Riociguat coated tablet 1.0 mg Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 51 💬
1150 Riociguat coated tablet 1.5 mg Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 51 💬
1151 Riociguat coated tablet 2.0 mg Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 51 💬
1152 Riociguat coated tablet 2.5 m Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 51 💬
1153 Riociguat coated tablet 2.5 mg Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 51 💬
1154 Risperidone Risperidone 1件: D00426 💬 2件: DRD2, HTR2A 💬 11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 5件:  8 , 156, 179, 187, 206 💬
1155 Rituximab combined with omalizumab Omalizumab 2件: D02994, D05251 💬 2件: FCER1A, MS4A1 💬 5件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 1件: 162 💬
1156 Rituximab-eu+ rituximab-pfizer x 2 courses Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
1157 Rituximab-pfizer (pf-05280586) x 3 courses Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
1158 Rituximab-us + rituximab-pfizer x 2 courses Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
1159 Ro4964913/f07-01 (commercial) - - - - 1件: 13 💬
1160 Roactemra 20 mg/ml concentrado para solución para perfusión - - - - 1件: 46 💬
1161 Roactemra 20 mg/ml concentrate for solution for infusion - - - - 1件: 46 💬
1162 Roactemra 20 mg/ml concentrate for solution for infusion. - - - - 1件: 46 💬
1163 Roactemra 20 mg/ml, concentrado para solución para perfusión - - - - 2件: 46, 271 💬
1164 Roactemra®ev product code: prd82321 - - - - 1件: 46 💬
1165 Ropinirole controlled-release (requip cr) for rls Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
1166 Rva576 (coversin) Nomacopan 1件: D11473 💬 1件: C5 💬 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 2件: 62, 109 💬
1167 S-warfarin Warfarin 3件: D00564, D01280, D08682 💬 2件: NQO1, VKORC1 💬 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 1件: 13 💬
1168 S95011 concentrate for solution for infusion - - - - 1件: 53 💬
1169 Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group) Amitriptyline 7件: D00326, D00809, D00823, D01355, D02691, D07448, D08623 💬 4件: GHR, OPRM1, SLC6A2, SLC6A4 💬 9件: Cytokine-cytokine receptor interaction, Estrogen signaling pathway, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Serotonergic synapse, Synaptic vesicle cycle 1件: 78 💬
1170 Secukinumab Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 7件: 13, 37, 41, 46, 160, 269, 271 💬
1171 Secukinumab (150 mg) Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
1172 Secukinumab (75 mg) Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
1173 Secukinumab (ain457) Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 46 💬
1174 Secukinumab (ain457) 150 mg s.c. Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
1175 Secukinumab 150 mg (2 injections per dose Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 269 💬
1176 Secukinumab 150 mg provided in 1.0 ml pre-filled syringes (pfss) for sc injection. Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
1177 Secukinumab 150 mg/1 ml solution for injection Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 2件: 37, 271 💬
1178 Secukinumab 150 milligram [cosentyx] Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
1179 Secukinumab 150mg Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 37 💬
1180 Secukinumab 300 mg, s.c. Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 41 💬
1181 Secukinumab 300mg Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 37 💬
1182 Secukinumab 75 mg/0.5 ml solution for injection Secukinumab 1件: D09967 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 1件: 271 💬
1183 Semi continuous intra-oral administration of ld/cd - - - - 1件:  6  💬
1184 Serum containing avonex - - - - 1件: 13 💬
1185 Sildenafil and losartan Losartan 4件: D00357, D02229, D08146, D08514 💬 2件: AGTR1, PDE5A 💬 18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 85 💬
1186 Simvastatin 40 mg film-coated tablets Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 13 💬
1187 Simvastatina sandoz 40 mg comprimidos recubiertos con película efg Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 13 💬
1188 Sin lv mediated ex vivo transduced autologous fibroblasts expressing codon-optimised col7a1 - - - - 1件: 36 💬
1189 Sin rv-mediated col7a1 corrected autologous skin equivalent - - - - 1件: 36 💬
1190 Sinemet (comparator) - - - - 1件:  6  💬
1191 Sinemet 100 mg + 25 mg compresse - - - - 1件:  6  💬
1192 Sinemet® controlled release (carbidopa/levodopa) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1193 Sinvastatina sandoz 40 mg comprimidos revestidos por película - - - - 1件: 13 💬
1194 Site specific standard of care comparison - - - - 2件: 38, 39 💬
1195 Sivatin 40 mg film-coated tablets - - - - 1件: 13 💬
1196 Sodium chloride Chloride ion 1件: D02056 💬 - - 20件:  6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬
1197 Sodium chloride (7%) Chloride ion 1件: D02056 💬 - - 1件: 299 💬
1198 Sodium chloride 0,9% Chloride ion 1件: D02056 💬 - - 1件: 299 💬
1199 Sodium chloride 0.9% Chloride ion 1件: D02056 💬 - - 1件: 14 💬
1200 Sodium chloride 6% Chloride ion 1件: D02056 💬 - - 1件: 299 💬
1201 Sodium chloride 7% Chloride ion 1件: D02056 💬 - - 1件: 299 💬
1202 Sodium chloride ph. eur. Chloride ion 1件: D02056 💬 - - 1件: 299 💬
1203 Sodium chloride solution Chloride ion 1件: D02056 💬 - - 3件: 11, 13, 228 💬
1204 Sodium chloride solution 0.9% Chloride ion 1件: D02056 💬 - - 3件: 60, 288, 299 💬
1205 Sodium chloride solvent Chloride ion 1件: D02056 💬 - - 1件: 228 💬
1206 Sodium pyruvate in 0.9% sodium chloride solution Chloride ion 1件: D02056 💬 - - 1件: 299 💬
1207 Soliris - 300 mg concentrato per soluzione per infusione - uso endovenoso 1 flaconcino (vetro) 30 ml (10 mg/ml) - - - - 1件: 109 💬
1208 Soliris 300 mg concentrado para solución para perfusión - - - - 1件: 109 💬
1209 Solu-cortef - - - - 3件:  6 , 81, 83 💬
1210 Solu-cortef (hydrocortisone) Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 83 💬
1211 Solu-cortef, powder for solution for injection, 100mg, and 'act-o-vial' - - - - 1件:  6  💬
1212 Soluble prednisolone tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 145 💬
1213 Solucion de cloruro de sodio sodium chloride solution Chloride ion 1件: D02056 💬 - - 1件: 228 💬
1214 Solvente cloruro de sodio sodium chloride solvent Chloride ion 1件: D02056 💬 - - 1件: 228 💬
1215 Somatropin (inn) recombinant dna orgin, escherichia coli Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 78 💬
1216 Sorbitol Sorbitol 1件: D00096 💬 - - 2件:  6 , 10 💬
1217 Spironolactone and conivaptan Conivaptan 3件: D00443, D01236, D07748 💬 3件: AVPR1A, AVPR2, NR3C2 💬 6件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 1件: 86 💬
1218 Spironolactone captopril carvedilol Captopril 4件: D00251, D00255, D00443, D03415 💬 7件: ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 18件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
1219 Ss-adrenergic cocktail - - - - 1件: 299 💬
1220 Stalevo (levodopa/ carbidopa/ entacapone) Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1221 Stalevo (levodopa/carbidopa/entacapone) Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
1222 Standard analgesia use [oxygen] Oxygen 1件: D00003 💬 - - 1件: 70 💬
1223 Standard continuous antiretroviral therapy - - - - 1件: 265 💬
1224 Standard gadolinium contrast Gadolinium - - - 1件: 13 💬
1225 Standard treatment with a conventional drug - - - - 1件: 13 💬
1226 Stelara 130 mg concentrate for solution for infusion - - - - 1件: 96 💬
1227 Sterile water Water 1件: D00001 💬 - - 1件: 78 💬
1228 Sterile water for injection Water 1件: D00001 💬 - - 1件: 78 💬
1229 Sterilised water for injections Water 1件: D00001 💬 - - 1件: 78 💬
1230 Subcutaneous hydrocortisone Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
1231 Subcutaneous hydrocortisone 10mg Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
1232 Subretinal injection of umbilical cord blood platelet-rich plasma (cb-prp) - - - - 1件: 90 💬
1233 Sucrose Sucrose 1件: D00025 💬 - - 3件: 62, 96, 97 💬
1234 Sulfur colloid - - - - 1件: 299 💬
1235 Sulphasalazine + hydroxychloroquine or prednisolone Hydroxychloroquine 9件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D08050 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
1236 Sulphsalazine, pentasa, asacol, colazide, depentum - - - - 1件: 97 💬
1237 Suspension containing 250 embryonated, viable trichuris suis ova (tso)/15ml - - - - 1件: 96 💬
1238 Suspension containing 250 embryonated, viable tso/15ml - - - - 1件: 96 💬
1239 Suspension containing 2500 embryonated, viable trichuris suis ova (tso)/15ml - - - - 1件: 96 💬
1240 Suspension containing 2500 embryonated, viable tso/15ml - - - - 1件: 96 💬
1241 Suspension containing 7500 embryonated viable trichuris suis ova/15ml - - - - 1件: 97 💬
1242 Suspension containing 7500 embryonated, viable trichuris suis ova (tso)/15ml - - - - 1件: 96 💬
1243 Symkevi 100mg/150mg film-coated tablets - - - - 1件: 299 💬
1244 Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin) Aldosterone 3件: D00150, D02014, D10528 💬 3件: AGTR1, AGTR2, NR3C2 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 222 💬
1245 T-peptide-crm197 conjugate - - - - 1件: 11 💬
1246 Tachipirina - 1000 mg compresse 8 compresse - - - - 1件: 14 💬
1247 Tachipirina - 500 mg compresse20 compresse - - - - 2件: 13, 53 💬
1248 Tacrolimus combined with prednisone Prednisone 3件: D00107, D00473, D08556 💬 6件: NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 222 💬
1249 Tadalafil 20 mg film-coated tablets Tadalafil 1件: D02008 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
1250 Tadalafil and ambrisentan upfront combination therapy Ambrisentan 2件: D02008, D07077 💬 2件: EDNRA, PDE5A 💬 9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件: 51, 86 💬
1251 Tafamidis meglumine 20 mg soft gelatin capsules Gelatin 4件: D00115, D01796, D06892, D09673 💬 1件: TTR 💬 1件: Thyroid hormone synthesis 1件: 28 💬
1252 Tafamidis meglumine 20mg soft gelatin capsule (clinical trial image) Gelatin 4件: D00115, D01796, D06892, D09673 💬 1件: TTR 💬 1件: Thyroid hormone synthesis 1件: 28 💬
1253 Tafamidis meglumine 20mg soft gelatin capsule (commerical image) Gelatin 4件: D00115, D01796, D06892, D09673 💬 1件: TTR 💬 1件: Thyroid hormone synthesis 1件: 28 💬
1254 Tat4 gel concentration a - - - - 1件: 265 💬
1255 Tat4 gel concentration b - - - - 1件: 265 💬
1256 Technetium sulfur colloid - - - - 1件: 299 💬
1257 Teriparatide [rdna origin] contains recombinant human parathyroid hormone (1-34) Parathyroid hormone 2件: D05364, D06078 💬 2件: PTH1R, PTH2R 💬 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 1件: 70 💬
1258 Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker Polyethylene glycol 2件: D03370, D06078 💬 1件: PTH1R 💬 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 1件: 235 💬
1259 Tetanus toxoid (tt) containing vaccine (td, tdap) Clostridium tetani toxoid antigen (formaldehyde inactivated) - - - 1件: 13 💬
1260 Tetracosactide Tetracosactide 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 4件: 83, 113, 145, 222 💬
1261 Tetracosactide acetate Acetate 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 2件: 83, 145 💬
1262 Tetracosactide hexaacetate Tetracosactide 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 113 💬
1263 Tetracosactide hexacetaat Tetracosactide 1件: D00284 💬 1件: MC2R 💬 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件: 222 💬
1264 The comprehensive treatment regimen of traditional chinese medicine - - - - 1件: 222 💬
1265 The generic name is warfarin and many producers will be involved Warfarin 3件: D00564, D01280, D08682 💬 2件: NQO1, VKORC1 💬 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 1件: 49 💬
1266 The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: - - - - 1件: 86 💬
1267 The pops study is collecting pk data on children prescribed the following drugs of interest per standard of care: - - - - 1件: 86 💬
1268 The yi-qi-qing-jie herbal compound - - - - 1件: 66 💬
1269 Timolol alcon 0.5% collyre Timolol 3件: D00378, D00603, D08600 💬 2件: ADRB1, ADRB2 💬 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 227 💬
1270 Tissue selective estrogen complex - - - - 1件: 13 💬
1271 To be confirmed - - - - 2件: 46, 97 💬
1272 Tobi 300mg/ 5ml solución para inhalación con nebulizador - - - - 1件: 299 💬
1273 Tocilizumab and iv steroids combination Tocilizumab 1件: D02596 💬 1件: IL6R 💬 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 1件: 41 💬
1274 Tofacitinib citrate (commercial image) Tofacitinib 1件: D09970 💬 4件: JAK1, JAK2, JAK3, TYK2 💬 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 1件: 46 💬
1275 Tofacitinib citrate (proposed commercial formulation - debossed) Tofacitinib 1件: D09970 💬 4件: JAK1, JAK2, JAK3, TYK2 💬 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 2件: 46, 97 💬
1276 Tofacitinib citrate (proposed commercial formulation debossed) Tofacitinib 1件: D09970 💬 4件: JAK1, JAK2, JAK3, TYK2 💬 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 1件: 46 💬
1277 Tofacitinib citrate (proposed commercial formulation – debossed) Tofacitinib 1件: D09970 💬 4件: JAK1, JAK2, JAK3, TYK2 💬 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 2件: 46, 97 💬
1278 Tofacitinib citrate (proposed commercial formulation- debossed) Tofacitinib 1件: D09970 💬 4件: JAK1, JAK2, JAK3, TYK2 💬 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 1件: 46 💬
1279 Tofacitinib citrate (proposed commercialformulation - debossed) Tofacitinib 1件: D09970 💬 4件: JAK1, JAK2, JAK3, TYK2 💬 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 1件: 97 💬
1280 Topical compound tripterygium Tripterygium wilfordii whole - - - 1件: 46 💬
1281 Tp05 coating a - - - - 1件: 97 💬
1282 Tp05 coating b - - - - 1件: 97 💬
1283 Tp05 coating d - - - - 1件: 97 💬
1284 Tp05 coating e - - - - 1件: 97 💬
1285 Tp05 coating h - - - - 1件: 97 💬
1286 Tracleer 62,5 mg comprimidos recubiertos con película - - - - 1件: 86 💬
1287 Traditional chinese medicinal mixture (composed of roucongrong and adjuvant) - - - - 1件:  6  💬
1288 Tralokinumab cohort 1 Tralokinumab 1件: D09979 💬 1件: IL13 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 1件: 85 💬
1289 Tralokinumab cohort 2 Tralokinumab 1件: D09979 💬 1件: IL13 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 1件: 85 💬
1290 Tramadol Tramadol 2件: D01355, D08623 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 5件: 46, 70, 78, 226, 271 💬
1291 Tramadol /acetaminophen Acetaminophen 3件: D00217, D01355, D08623 💬 3件: OPRM1, PTGS1, PTGS2 💬 26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 271 💬
1292 Tramadol hydrochloride + acetaminophen Acetaminophen 3件: D00217, D01355, D08623 💬 3件: OPRM1, PTGS1, PTGS2 💬 26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 46 💬
1293 Tramadol with ropivacaine Ropivacaine 4件: D01355, D04048, D08490, D08623 💬 6件: OPRM1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 6件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction 1件: 70 💬
1294 Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col17a1-encoding retroviral vector - - - - 1件: 36 💬
1295 Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col7a1-encoding retroviral vector - - - - 1件: 36 💬
1296 Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col7a1-encoding retroviral vector, obtained from secondary culture of ex vivo expanded autologous human keratinocytes. - - - - 1件: 36 💬
1297 Transplant conditioning with mobilization and alemtuzumab Alemtuzumab 1件: D02802 💬 - - 1件: 65 💬
1298 Transplant conditioning with mobilization only - - - - 1件: 65 💬
1299 Treatment with topical superpotent corticosteroid therapy - - - - 1件: 162 💬
1300 Trexan+salazopyrin+oxiklorin+prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
1301 Trexan+salazopyrin+oxiklorin+prednisolone + infliximab Infliximab 9件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02598, D03301 💬 2件: NR3C1, TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
1302 Triple combination therapy - - - - 1件: 299 💬
1303 Triptolide-containing formulation Triptolide - - - 1件: 67 💬
1304 Triterpene dry extract from birch cork - - - - 1件: 36 💬
1305 Tysabri 300 mg concentrado para solución para perfusión - - - - 1件: 13 💬
1306 Tysabri 300 mg concentrate for solution for infusion - - - - 1件: 13 💬
1307 Ultrasound microbubble contrast agent - - - - 1件: 96 💬
1308 Umbilical cord blood - - - - 1件: 60 💬
1309 Umbilical cord blood after myeloablative conditioning - - - - 1件: 60 💬
1310 Umbilical cord blood after reduced-intensity conditioning - - - - 1件: 60 💬
1311 Umbilical cord blood transplantation - - - - 1件: 60 💬
1312 Umbilical cord blood unit - - - - 1件: 333 💬
1313 Umbilical cord derived mesenchymal stem cell (uc -msc) transplantation - - - - 2件: 93, 296 💬
1314 Umbilical cord derived mesenchymal stem cells - - - - 1件: 13 💬
1315 Umbilical cord mesenchymal stem cell - - - - 1件: 113 💬
1316 Umbilical cord mesenchymal stem cell (uc-msc) - - - - 1件: 90 💬
1317 Umbilical cord mesenchymal stem cells - - - - 5件: 13, 46, 57, 97, 113 💬
1318 Umbilical cord-derived mesenchymal stem cells (uc-mscs) Human Umbilical Cord Mesenchymal Stem Cells - - - 1件: 46 💬
1319 Unrelated cord blood - - - - 1件: 65 💬
1320 Unrelated umbilical cord blood transplant - - - - 1件: 19 💬
1321 Upadacitinib - direct compression-yellow Upadacitinib 1件: D10994 💬 1件: JAK1 💬 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 1件: 97 💬
1322 Upadacitinib -direct compression-yellow Upadacitinib 1件: D10994 💬 1件: JAK1 💬 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 1件: 97 💬
1323 Urbason 40 mg comprimidos - - - - 1件: 13 💬
1324 Ursodeoxycholic acid combination of immunosuppressive agents Ursodeoxycholic acid 1件: D00734 💬 1件: NR1H4 💬 1件: Bile secretion 2件: 93, 95 💬
1325 Ursodeoxycholic acid combined with total glucosides of paeony Ursodeoxycholic acid 1件: D00734 💬 1件: NR1H4 💬 1件: Bile secretion 1件: 93 💬
1326 Ursofalk® 500 mg film-coated tablets - - - - 1件: 93 💬
1327 Us tap bupivacaine/epinephrine Bupivacaine 5件: D00095, D00996, D01450, D02149, D07552 💬 14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 96 💬
1328 V1512 and entacapone Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 1件:  6  💬
1329 Valproid acid plus corticosteroids - - - - 1件: 26 💬
1330 Vastarel 20mg film coated tablets - - - - 1件: 58 💬
1331 Vector viral adenoasociado de serotipo 9 que contiene el gen de la sulfamidasa humana - - - - 1件: 19 💬
1332 Vehice control - - - - 1件: 96 💬
1333 Vehicle control - - - - 1件: 53 💬
1334 Verapamil Verapamil 2件: D00619, D02356 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件: 96, 140, 167 💬
1335 Verapamil sr Verapamil 2件: D00619, D02356 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 167 💬
1336 Vett lentiviral con gene abca4 - - - - 1件: 301 💬
1337 Viokase 16 (pancrelipase) + nexium Pancrelipase 1件: D05349 💬 - - 1件: 298 💬
1338 Volibris 10 mg comprimidos recubiertos con película - - - - 1件: 86 💬
1339 Volibris 5 mg comprimidos recubiertos con película - - - - 1件: 86 💬
1340 Von willebrand factor and coagulation factor viii in combination Beroctocog alfa - - - 1件: 288 💬
1341 Von willebrand factor ristocetin cofactor Von Willebrand Factor Human - - - 1件: 288 💬
1342 Vwd factor viii concentrate Beroctocog alfa - - - 1件: 288 💬
1343 Vwf-containing products - - - - 1件: 288 💬
1344 Vx-661 plus ivacaftor combination Ivacaftor 1件: D09916 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 1件: 299 💬
1345 Warfarin Warfarin 3件: D00564, D01280, D08682 💬 2件: NQO1, VKORC1 💬 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
1346 Warfarin 10 mg Warfarin 3件: D00564, D01280, D08682 💬 2件: NQO1, VKORC1 💬 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 2件: 96, 97 💬
1347 Warfarin sodium Warfarin 3件: D00564, D01280, D08682 💬 2件: NQO1, VKORC1 💬 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 1件: 49 💬
1348 Warfarin+ vitamin k Phylloquinone 4件: D00148, D00564, D01280, D08682 💬 2件: NQO1, VKORC1 💬 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 1件: 46 💬
1349 Water Water 1件: D00001 💬 - - 22件:  2 ,  5 ,  6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬
1350 Water for injection Water 1件: D00001 💬 - - 1件: 35 💬
1351 Water for injections Water 1件: D00001 💬 - - 1件: 299 💬
1352 Water for injections, ep Water 1件: D00001 💬 - - 1件: 299 💬
1353 White chocolate (0% cocoa) Cocoa - - - 1件:  6  💬
1354 Xeljanz 5 mg film-coated tablets - - - - 2件: 46, 97 💬
1355 Xeljanz 5mg film-coated tablets - - - - 1件: 97 💬
1356 Xenon contrast agent Xenon 2件: D01901, D06339 💬 - - 1件: 22 💬
1357 Xyzal - 20 compresse ri - - - - 1件: 53 💬
1358 Yondelis 0,25 mg polvo para concentrado para solución para perfusión - - - - 1件: 159 💬
1359 Yondelis 0.25 mg powder for concentrate for solution for infusion. - - - - 1件: 159 💬
1360 Yondelis 1 mg polvo para concentrado para solución para perfusión - - - - 1件: 159 💬
1361 Yondelis 1 mg powder for concentrate for solution for infusion. - - - - 1件: 159 💬
1362 Z102 (prednisolone and dipyridamole). Dipyridamole 9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 3件: NR3C1, PDE4A, PDE5A 💬 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
1363 Zinc and copper Copper - - - 1件:  2  💬
1364 Zuglimet - 500 mg compresse rivestite con film 30 compresse in blister pvc/al - - - - 1件: 67 💬

先頭へ